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Abstract
Tissue Enginnering emerges as a potential and alternative therapeutic process
to treat severely injured patients with minimally invasive techniques. Cartilage
and bone injuries occur due to several reasons and they compromise quality of
life. This thesis was focused on development of biomaterials that could mimic
cartilage and bone tissue, using only natural substances, gelatin and/or colla-
gen, crosslinked with genipin (GP) and hydroxyapatite (HA) . These materials
are cheap and easy to handle, and in particular collagen, represents a chemo-
attractor factor, that may help cellular colonization. First of all genipin reaction
was studied to establish reaction rate constant and crosslinking degree as func-
tion of genipin concetrations. The optimal genipin concentration was decided
primarly assuring that it was not cytotoxic, meseauring its release in acqueous
enviroment. Then elastic moduli of scaﬀolds prepared with diﬀerent GP con-
centrations, diﬀerent protocols and diﬀerent HA concentrations were measured
taking into account that scaﬀolds had to present mechanical properties suited to
the implant site. Roughness surface of scaﬀolds, was also investigated with SEM,
to ensure an optimal integration with implant site and to verify the presence of
a right porosity to allow its cell colonisation. Bone scaﬀolds were arranged to
reproduce a HA gradient, an important bone feature, and their anisotropy was
valueted. Biocompatibility tests, in vitro tests, for cartilage and bone biomateri-
i
als were performed using primary and immortalised cells. Finally preliminary in
vivo tests using small animal models, rats with a femur lesion, were performed
for cartilage and bone substitute, selected on the basis of their mechanical prop-
erties. The aim was to follow bone and cartilage regeneration, after injection of
biomaterials, and to compare it with the physiological regeneration.
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Bone and cartilage
Introduction
Cartilage and bone injuries occur due to several reasons including degenerative,
surgical, and traumatic processes, which significantly compromise quality of life
and for this reason, they have long presented a challenge to physicians. Currently,
millions of patients are suﬀering from bone and cartilage defects. Attention is
focused especially on cartilage that has a reduced capacity to repair, due to the
low mitotic activity of chondrocytes. On the contrary, bone has a high self repair
capacity but for a large bone defect a surgical intervention is often required. In
this chapter some traditional clinic techniques with their advantages and disad-
vantages, and the promising development of Tissue Engineering (TE) for bone
and cartilage will be described. TE represents as a potential alternative therapeu-
tic process to treat severely injured patients with minimally invasive techniques.
Many and diﬀerent are the materials used to obtain a suited biomaterial for bone
and cartilage, this work is focused only on the use of natural components gelatin,
collagen, hydroxyapatite (HA) and genipin. These materials are easy to obtain,
to process, to sterilize and to handle in the surgical room (without preparation
procedures, thus avoiding risks of infection).
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1.1 Cartilage
1.1.1 Cartilage defects
In 1743, the famous English anatomist William Hunter wrote ‘an ulcerated car-
tilage is a trouble-some problem... that, once destroyed, it is not recovered’ [1].
Why so many problems derives from a cartilage damage? This is a tissue that has
a low self-repair capacity due to its particular and unique features: it is predomi-
nantly composed of a unique extra-cellular matrix (ECM), made of proteoglycans,
negatively charged glycosaminoglyan (GAG) chains that swell and hydrate car-
tilage, and collagen type II, a fibrillar collagen that traps the proteoglycans and
provides tensile strength. The biomecanical properties derive from ECM, and
to regain a functional joint, cartilage defects would ideally be replaced by tissue
of this precise composition. After a damage, which does not penetrate to the
subchondral bone, intrinsic cartilage repair has diﬀerent barriers: it is avascular,
meaning that the nutrients required for energetic repair processes and the re-
moval of metabolic waste products are limited by diﬀusion to ⁄ from surrounding
tissues. It is relatively acellular; therefore few cells are available to aﬀect repair
[2]. These obstacles conspire to limit repair of defects to a fibrocartilaginous
substitute tissue with diﬀerent molecular composition (more type I collagen, less
proteoglycan) and biomechanical behaviour (less proteoglycan and collagen type
II, more collagen type I), compared with the original hyaline tissue [3]. On the
contrary, a full-thickness (osteochondral) defect goes through the subchondral
bone, accessing the bone marrow cells, including mesenchymal stem cells and
also growth factors and cytokines [4]. The repair consists in the formation of a
fibrocartilaginous tissue in the defect void. The events leading up to the forma-
tion of the repair tissue in a rabbit model have been characterised, indicating an
immediate response to penetration of the subchondral bone in a full thickness
defect with, in some cases, formation of hyaline-like articular cartilage[5]. This
repair tissue is a poor substitute for articular cartilage, and a degeneration of
both repaired and adjacent native tissues will be often observed after long-term
follow-up (figure 1.1.1) [6].
Today, cartilage damage is still an issue for physicians and patients, and there
is still no universally accepted and successful treatment approach for damaged
2
Chapter 1. Bone and cartilage 1.1. Cartilage
24
S.N. Redman et al.                                                                                                                                                     Review of Cartilage Repair Strategies
is not only the absence of access to the bone marrow cells
that prevents the repair of partial thickness defects, there
are clearly other mechanisms involved that remain to be
fully elucidated.
Full Thickness Defects
Full thickness defects pass through the zone of calcified
cartilage and penetrate the subchondral bone thereby
gaining access to the cells that reside in the bone marrow
space including the mesenchymal stem cells located therein
(Fig. 1B).  The repair response elicited by this type of defect
results in the formation of a fibrocartilaginous tissue in
the defect void.  The events leading up to the formation of
the repair tissue in a rabbit model have been characterised
(Shapiro et al., 1993), indicating an immediate response
to penetration of the subchondral bone in a full thickness
defect with, in some cases, formation of hyaline-like
articular cartilage.  This repair tissue is a poor substitute
for articular cartilage and, with time, there is marked
degeneration of the repair tissue and continued
degeneration of the native articular cartilage. It has been
noted (Shapiro et al., 1993) that during this process, the
tissue adjacent to the wound margins becomes necrotic
and apart from occasional chondrocyte cluster formation,
little to no remodelling occurs.  It was also noted that the
empty lacunae observed in the native tissue at the wound
margins were not filled by either native migrating
chondrocytes or mesenchymal cells from the defect void.
By light microscopy, continuity between the native and
repair tissue was observed but polarised light microscopy
revealed no true integration of the two matrices and also
revealed frequent regions of discontinuity.  Although the
outcome of the natural repair response to full thickness
defects is poor, many operative procedures to alleviate
joint pain are based upon this mechanism of repair.
Repair Strategies
Arthroscopic Repair Procedures
Arthroscopic lavage and debridement are often used to
alleviate joint pain.  Lavage involves irrigation of the joint
during arthroscopy.  This rinsing of the joint appears to
alleviate pain although the mechanism for this is unclear
(Livesley et al., 1991).  The procedure may remove debris
from the joint space thereby alleviating pain.  Debridement
is the arthroscopic removal of damaged tissue from the
joint, which has also been shown to alleviate pain and
when used in conjunction with lavage, pain relief appears
to last longer (Chang et al., 1993).  Both of these
procedures are used routinely to alleviate joint pain and
have been shown to be successful in treating the early
stages of osteoarthritis (Jackson and Dieterichs, 2003;
Shannon et al., 2001).  Both lavage and debridement,
however, do not induce repair of articular cartilage and  a
recent study has demonstrated that pain relief observed
following debridement and lavage procedures may be no
more than a placebo effect following surgery (Moseley et
al., 2003).
Many arthroscopic procedures used to induce repair
of articular cartilage take advantage of the intrinsic repair
response, observed upon penetration of the subchondral
bone in full thickness defects.  These techniques include
Figure 1.  Diagram illustrating a partial thickness focal defect in articular cartilage (A) and a full thickness defect
that penetrates to the subchondral bone (B).Figure 1.1.1: A partial thickness focal defect in articular cartilage (A) and a full
thickness defect involving the subchondral bone (B).
cartilag . The common treatmentes for cartilage includes [7]:
• arthroscopic debridement, in which loose cartilage is trimmed;
• microfractu e, in which bone marrow based epair is timulated;
• autologous osteochondral grafting, in which bone-cartilage plugs are har-
vested from non-weight bearing joint sites and implanted directly into the
defect;
• autologous chondrocyte implantation , two-stage procedure involving har-
vest of chondrocytes, growth in vitro, then reimplantation.
These therapies were unsuccessful fo a long term repair, they showed many side
eﬀects and they were limited to small lesions.
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1.1.2 Tissue engineering
Tissue engineering has emerged as a new multidisciplinary field, that joins the
latest developments in cell/molecular biology, materials science and engineering,
chemistry and medical sciences towards the development of hybrid substitutes.
These are obtained combining biodegradable supports (scaﬀolds), cells and sig-
nalling molecules, such as growth factors, aimed at restoring tissue or organs
functions, using the natural signalling pathways and components of the organism
[8]. Tissue engineering strategies have potential to be used in the regeneration
of a series of tissues and organs and are especially adequate for the regener-
ation of articular cartilage, due to its own limited repair capacity. A critical
requirement is the correct choice of the materials and the design of the scaﬀold
structure. Even for a single tissue, the ‘ideal scaﬀold’ does not yet exist, and
much more investigative work is needed on diﬀerent materials combinations, the
eﬀect of porosity (porosity content, pore size distribution and interconnectivity),
adequate cell sources and the best delivery strategies for growth factors [9]. Scaf-
folds will provide a shape, drive tissue development and permit the convenient
delivery of cells into patients, it should be biodegradable and the degradation rate
should match the extracellular matrix produced. Generically, three-dimensional
(3D) porous scaﬀolds or hydrogels are the most widespread solutions for con-
structs, due to the high standard of cellular attachment and mechanical stability
that is attained. The macrostructure of the scaﬀolds plays an important role
also on the proliferation and migration of seeded cells into the matrix. Many
types of materials have been proposed for both cartilage tissue engineering, most
of them biocompatible and biodegradable polymers. Here they are grouped on
the the basis of their diﬀerent origin. Natural polymers are the most suitable
to favor cell growing, they contain important domains that send signals to cells
to favour their development, but at the same time these polymer could cause
antigenicity [10]. The most common natural polymers are proteins particurarly
those extracted from extracellular matrix, i.e collagen and glycosaminoglycan,
or polypeptides, polysaccharides (chitosan, hyaluronic acid and alginate). Syn-
thetic polymers can be modulated in many ways such as mechanical properties
(strength and modules), degradation rate, molecular weight and chemical mod-
ification. In addition, they can be manufactured in a large scale. The most
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popular biodegradable synthetic polymers include poly (α-hydroxy acids) such as
poly (glycolic acid) PGA , poly (D,L-lactic acid)PLA, and their copolymers poly
(lactic-co-glycolic acid) PLGA, poly(ε-caprolactone), poly(propylene fumarate),
poly(dioxanone), poly orthoesters, polycarbonates. Poly (ethylene glycol) PEG
is a linear polyether that is used extensively in biomedical applications due to its
hydrophilic and highly biocompatible properties, and at low molecular weight can
be safely excreted by metabolism in body. Some products, such as Hyaﬀ®-11
(FIDIA Advanced Biopolymers, Italy) are already commercialized.
1.2 Bone
1.2.1 Bone repair
Bone possesses the intrinsic capacity for regeneration as part of the repair process
in response to injury, as well as during skeletal development or continuous remod-
elling throughout adult life. Bone regeneration is comprised of a well-orchestrated
series of biological events of bone induction and conduction, involving a number
of cell types and intracellular and extracellular molecular-signalling pathways,
with a definable temporal and spatial sequence, in an eﬀort to optimise skeletal
repair and restore skeletal function [11]. In the clinical setting, the most com-
mon form of bone regeneration is fracture healing, during which the pathway of
normal fetal skeletogenesis, including intramembranous and endochondral ossifi-
cation, is recapitulated [12]. Unlike in other tissues, the majority of bone injuries
(fractures) heal without the formation of scar tissue, and bone is regenerated
with its pre-existing properties largely restored, and with the newly formed bone
being eventually indistinguishable from the adjacent uninjured bone [11]. When
this natural process do not occur, because of fracture non-unions or large scale
traumatic bone injury, surgical intervention is warranted. A surgical approach
concerns the use of rigid internal fixation, which is a nonresorbable material and
are susceptible to long-term fatigue and fracture. Bone grafting is a commonly
performed surgical procedure to augment bone regeneration in a variety of or-
thopaedic and maxillofacial procedures, with autologous bone being considered
as the ‘gold standard’ bone-grafting material, as it combines all properties re-
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quired in a bone-graft material: osteoinduction (bone morphogenetic proteins
(BMPs) and other growth factors), osteogenesis (osteoprogenitor cells) and os-
teoconduction (scaﬀold) [13]. Furthermore, because it is the patient’s own tissue,
autologous bone is histocompatible and non-immunogenic, reducing to a mini-
mum the likelihood of immunoreactions and transmission of infections. Neverthe-
less, harvesting requires an additional surgical procedure, with well documented
complications and discomfort for the patient, and has the additional disadvan-
tages of quantity restrictions and substantial costs [14, 15]. An alternative is
allogeneic bone grafting, obtained from human cadavers or living donors, which
bypasses the problems associated with harvesting and quantity of graft mate-
rial. There are issues of immunogenicity and rejection reactions, possibility of
infection transmission, and cost [16]. Given the shortcomings of autografts and
allografts and the large demand for bone grafts, tissue engineering approaches
emerged as a potential alternative therapeutic process to treat severely injured
patients with minimally invasive techniques. Tissue engineering represents one
promising strategy.
1.2.2 Bone tissue engineering
Bone tisse engineering develops graft substitutes formed from a variety of ma-
terials (natural and synthetic polymers, ceramics, and composites) that are de-
signed to mimic the three-dimensional characteristics of autograft tissue while
also providing the ability to sustain cells seeded onto the construct [17, 18, 19].
In addition to appropriate mechanical properties, the scaﬀold must also have the
right internal micro-architecture with interconnected pores of 200-400 ￿m diam-
eter (the average size of the human osteon is approximately of 223 ￿m) [20].
Pore size is known to aﬀect cellular aﬃnity and viability by influencing cellular
movement, binding and spreading, intracellular signaling, and transport of nutri-
ents and metabolites [21]. The inorganic phase is represented by ceramics, such
as hydroxyapatite (HA) or other calcium phosphate (Ca-P) ceramics (including
tricalcium phosphate, TCP) or bioactive glasses (such as Bioglass®). They are
known to promote, when implanted, the formation of a bone-like apatite layer
on their surfaces. This is considered to be a positive characteristic in terms of
bone-bonding behaviour, assuring enhanced fixation of the implant [22, 23, 24].
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Even if hydroxyapatite, calcium phosphate and a wide variety of ceramic ma-
trices are appropriate for cell transport as they stimulate their diﬀerentiation
and bone growth, they are not osteoinductive and they are reabsorbed relatively
slowly. Also, there are problems associated with biodegradability, inflammatory
and immunological reactions when they are used as carriers of osteoinductive fac-
tors. To overcome these drawbacks the inorganic phase is combined with natural
or synthetic polymers or polymer precursors, above mentioned, that will allow
produce bioactive, inert, biodegradable or injectable composites [25]. Injectable
materials (small particles or semi-liquid polymers that can be cross-linked in situ)
are preferable for irregular defects reconstruction, while solid materials are more
appropriate for large bone defects [26]. These materials can also acellular or
celluar. Acellular materials can be solid, absorbable fillers that will disappear
with time, or porous scaﬀold that can be rapidly colonized by cells. Instead,
cellular materials are structures in which a cellular component is embedded prior
to implantation. Inclusion of growth factors in the scaﬀolds may be a route for
its controlled delivery during the diﬀerentiation process. A briefly description of
materials used in this thesis will follow in the next section.
1.3 Material selection
1.3.1 Gelatin
Gelatin is widely used in the pharmaceutical industry as well as in the biomed-
ical field: hard and soft capsules, microspheres, sealants for vascular prostheses,
wound dressing and adsorbent pad for surgical use are among its most frequent
applications. Gelatin is obtained by thermal denaturation or physical and chem-
ical degradation of collagen which involves the breaking of the triple-helix struc-
ture. The result is a biodegradable, biocompatible and nonimmunogenic product,
suitable for medical applications [27]. At a temperature of about 40°C, gelatin
aqueous solutions are in the sol state and form physical thermoreversible gels
on cooling. During gelling, the chains undergo a conformational disorder-order
transition and tend to recover the collagen triple-helix structure [28]. As a bio-
material, gelatin displays several attractivness: it is a natural polymer which has
7
1.3. Material selection Chapter 1. Bone and cartilage
Figure 1.3.1: Gelatin structural unit.
not shown antigenity, it is completely resorbable in vivo and its physicochemical
properties can be suitably modulated [29, 30].
Commercially there are two processes for the production of gelatine from col-
lagen. In the first method, the alkali process, the raw material is treated with a
basic suspension to dissolve impurities. It is suitable to destroy certain chemical
crosslinkages still present in a more complex collagen e.g. collagen from bovine
skin and bone, but this process requires longer time, normally several weeks. The
gelatin obtained from this process is referred to as type-B gelatin. The second or
acid process does not involve a pretreatment, is especially suitable for less fully
crosslinked materials such as pig skin collagen. Pig skin collagen is less complex
than the collagen found in bovine hides. Acid treatment is faster than alkali
treatment and normally requires from 10 to 48 hours. This gelatin is called type-
A gelatin. It is important to know by which of these two processes the gelatin
was made, since the two types diﬀer in properties. They have diﬀerent viscosity,
gel strength (Bloom index) and diﬀerent isotonic point. Gelatin obtained is a
heterogeneous mixture of single or multi-stranded polypeptides, each with ex-
tended left-handed proline helix conformations and containing between 50 - 1000
amino acids. Gelatin contains many glycine (almost 1 in 3 residues, arranged
every third residue), proline and 4-hydroxyproline residues. A typical structure
is -Ala-Gly-Pro-Arg-Gly-Glu-4Hyp-Gly-Pro- (fig. 1.3.1).
Thanks to the large number of functional side groups it contains, gelatin
readily undergoes chemical cross-linking, which is very important for its possible
use as a biomaterial. In fact, as collagen based biomaterials are rapidly degraded
in vivo, their structure must be reinforced so that they will not significantly alter
8
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in the body for the required period. This is usually achieved through the use of
cross-linking agents. Gelatin used in this work is gelatin type A from porcine
skin (Sigma Aldrich, Italy).
1.3.2 Collagen
Collagen is the major insoluble fibrous protein in the extracellular matrix and
in connective tissue. There are at least 16 types of collagen, but 80%-90% of
collagen in the body consists of type I, II and III (figure1.3.2).
Type Molecule 
Composition 
Structural Features Representative 
Tissues 
Fibrillar Collagens 
I [!1(I)]2[!2(I)] 300-nm-long fibrils Skin, tendon, bone, 
ligaments, 
dentin,interstitial 
tissues 
II [!1(II)]3 300-nm-long fibrils Cartilage, vitreous 
humor 
III [!1(III)]3 300-nm-long fibrils; 
often with type I 
Skin, muscle, blood 
vessels 
V [!1(V)]3 390-nm-long fibrils 
with globular N-
terminal domain; often 
with type I 
Similar to type I; also 
cell cultures, fetal 
tissues 
Fibril-Associated Collagens 
VI [!1(VI)][!2(VI)] Lateral association 
with type I; periodic 
globular domains 
Most interstitial  
tissues 
IX [!1(IX)][!2(IX)] 
[!3(IX)] 
Lateral association 
with type II; N-
terminal globular 
domain; bound 
glycosaminoglycan 
Cartilage, vitreous 
humor 
Sheet-Forming Collagens 
IV [!1(IV)]2[!2(IV)] Two-dimensional 
network 
All basal laminaes 
 
Figure 1.3.2: Principal types of collagen
These collagen types are usually packed togheter to form long thin fibrils.
While type IV forms a two dimensional reticulum, several other types associate
with fibril-type collagens linking them to each other or to other matrix compo-
nents. At one time it was thought that all collagens were secreted by fibroblasts
in connective tissue, but we now know that numerous epithelial cells make cer-
tain types of collagens. The first collagen characterized was type I collagen. Its
9
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fundamental structure is a long and thin protein made of three α chains subunits,
arranged in a right-handed triple helix. There are at least 30 diﬀerent types of
α chains that may result in theory in 20000 diﬀerent triple helices, but we know
only 19 types. The triple-helical structure of collagen arises from an unusual
abundance of three amino acids: glycine, proline, and hydroxyproline. These
amino acids make up the characteristic repeating motif Gly-Pro-X, where X can
be any amino acid. Each amino acid has a precise function. The side chain of
glycine, an H atom, is the only one that can fit into the crowded center of a
three-stranded helix. Hydrogen bonds linking the peptide bond NH of a glycine
residue with a peptide carbonyl group in an adjacent polypeptide help hold the
three chains together. The fixed angle of the C-N peptidyl-proline or peptidyl-
hydroxyproline bond enables each polypeptide chain to fold into a helix with a
geometry such that three polypeptide chains can twist together to form a three-
stranded helix. Many three-stranded type I collagen molecules pack together
side-by-side, forming fibrils with a diameter of 50-200 nm. In fibrils, adjacent
collagen molecules are displaced from one another by 67 nm, about one-quarter
of their length. This staggered array produces a striated eﬀect that can be seen
in electron micrographs of stained collagen fibrils; the characteristic pattern of
bands is repeated about every 67 nm (figure 1.3.3 on the next page).
Type I collagen fibrils have enormous tensile strength; that is, such collagen can
be stretched without being broken. These fibrils, roughly 50 nm in diameter
and several micrometers long, are packed side-by-side in parallel bundles, called
collagen fibers [31](figure 1.3.4 on page 12). This collagen type has been used in
this work, it was extracted from Wistar rat tail [32].
The critical aspect in using collagen gel as a biomaterial, is that its mechanical
strength is too small and easily deforms its triple-helix structure into a random
coil structure when heated and it dissolves in water. Like gelatin to overcome
these problems, chemical crosslinking methods have been used.
1.3.3 Genipin
Genipin has been used in this work as crosslinker, chosen among the most used
crosslinkers, on the basis of its chemical features and reduced toxicity. In chemical
cross-linking methods, cross-linkers are used to bond functional groups of amino
10
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Figure 1.3.3: Schematic diagram of Type I collagen fibril structure.
acids. Commonly used chemical cross-linkers include formaldehyde, glutaralde-
hyde, polyepoxy compounds, tannic acid, dimethyl suberimidate, carbodiimides
and acyl azide. However, these synthetic cross-linking reagents were relatively
highly cytotoxic, impairing the biocompatibility of bioprostheses [33, 34]. This
is the reason for the increasing demand for a cross-linking reagent that can form
stable and biocompatible cross-linked products, without causing problems of cy-
totoxicity. Genipin showed to be a low-toxic and naturally occurring cross-linking
agent [35, 36, 37]. It was about 10000 times less cytotoxic than glutaraldehyde
[35], and it can form stable cross-linked products with resistance against enzy-
matic degradation that is comparable to that of glutaraldehyde-fixed tissue [38].
Genipin and its related iridoid glucosides, are extracted from the fruits of Gar-
denia jasminoides Ellis. The fruit is an oriental folk medicine which has been
included in traditional formulations. Its folkloric use was for the treatment of
inflammation, jaundice, headache, edema, fever, hepatic disorders and hyperten-
sion, and its pigments were used as food colorants in oriental countries. The
pharmacological actions of the whole fruit, such as protective activity against ox-
idative damage, cytotoxic eﬀect, antiinflammatory activity and fibrolytic activity
have already been elucidated [39]. Among the drug extracted form the dried fruit
11
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Figure 1.3.4: The structure of collagen, from the α chains to the fiber.
of gardenia, geniposide is one of the major iridoid glycosides and is hydrolyzed
to the aglycone genipin (figure 1.3.5).
yet. Genipin has been shown to inhibit hepatocyte apoptosis
induced by transforming growth factor h1 via the interfer-
ence with mitochondrial permeability transition (Yamamoto
et al., 2001) and protect hippocampal neurons from Alz-
heimer’s amyloid h protein toxicity (Yamazaki et al., 2001).
Although gardenia fruit has been used for the treatment of
inflammation, its antiinflammatory mechanism remains to
be investigated. One finding suggests that geniposide has an
antiinflammatory effect (Nishizawa et al., 1988). Because
geniposide is transformed into genipin by bacterial enzymes
in the body (Akao et al., 1994), it may be that genipin
mainly plays an important role in the efficacy. Thus, when
geniposide is orally administered, genipin seems to be
effectively produced in the intestine and then absorbed. In
this article, we have presented some pharmacological
actions of genipin.
2. Materials and methods
2.1. Chemicals
Dulbecco’s Modified Eagle’s Medium (DMEM), fetal
bovine serum, penicillin-streptomycin and trypsin-EDTA
were obtained from Gibco-BRL (Gaithersburg, MD).
LPO-586k for the lipid peroxidation assay was obtained
from Bioxytech (Gagny, France). Bradford protein dye
reagent was purchased from Bio-Rad (Melvile, NY). Gen-
ipin was purchased from Wako (Osaka, Japan). Glucose, 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), croton oil, ascorbic acid, indomethacin, Griess
reagent, sodium nitrite, sodium dodecyl sulfate (SDS),
EDTA, leupeptin, pepstatin, phenylmethanosulfonyl fluo-
ride (PMSF), Tween 20, retinoic acid, dimethyl sulfoxide
(DMSO), Trizma base, xanthine, xanthine oxidase, HEPES,
H2O2, 1,1-diphenyl-2-picrylhydrazyl (DPPH), BHT (butyl-
ated hydroxytoluene), interferon-g (IFN-g) and lipopolysac-
charide from Escherichia coli were purchased from Sigma
(St. Louis, MI). Multi-well plates were obtained from Nalge
Nunc International (Rocklide, Denmark). All other chem-
icals were of reagent grade or better.
2.2. Cell culture
RAW 264.7, a murine macrophage cell line, was
obtained from American Type Culture Collection (Mana-
ssas, VA). Cells were cultured in phenol red-free DMEM
containing 100 U/ml penicillin G, 100 Ag/ml streptomycin
and 10% heat-inactivated fetal bovine serum and were
maintained at 37 jC in a humidified incubator containing
5% CO2.
2.3. Animals
Male ICR mice (about 25 g) or female Sprague–Dawley
rats (130–150 g) were inbred and grown in the animal room
at the College of Pharmacy, Sookmyung Women’s Univer-
sity, Seoul, Korea. The animal room was maintained at
23F 2 jC with a 12-h light/dark cycle. Food and tap water
were supplied ad libitum. The ethical guidelines described
in the NIH Guide for Care and Use of Laboratory Animals
were followed throughout the experiments. The fertilized
eggs used in this work were purchased from Pulmuone
Food, Seoul, Korea.
2.4. Assay for inhibition of lipid peroxidation
For the determination of the ability to inhibit iron-
dependent lipid peroxidation, rat brain homogenate (20
mg/ml) was prepared in 20 mM Tris buffer (pH 7.4) and
centrifuged at 3000! g for 10 min at 4 jC, and the
supernatant was used for the lipid peroxidation assay. The
incubation mixture in a final volume of 200 Al contained rat
brain homogenate (195 Al), 100 AM Fe2 +, 400 AM ascorbic
acid and various concentrations of genipin dissolved in
DMSO. The resulting lipid peroxidation was evaluated by
the formation of malondialdehyde (Nair et al., 1986).
Malondialdehyde, the main decomposition product of per-
oxides derived from polyunsaturated fatty acids, was deter-
mined by chromogenic reagent N-methyl-2-phenylindole,
which reacts with malondialdehyde to yield a stable chro-
mophore at 45 jC for 60 min (Bioxytech; Chabrier et al.,
1999). The reaction mixture was centrifuged at 15,000! g
for 10 min to obtain a clear supernatant, and then the
absorbance was measured at 586 nm.
2.5. Assay for DPPH radical scavenging activity
DPPH radical scavenging activities of genipin were
tested according to the method previously described (Song
et al., 2003). In brief, reaction mixtures containing various
concentrations of genipin dissolved in DMSO and 300
AM DPPH solution in a 96-well microtiter plate were
incubated at 37 jC for 30 min, and absorbance was
measured at 515 nm.
Fig. 1. The chemical structures of genipin and geniposide.
H.-J. Koo et al. / European Journal of Pharmacology 495 (2004) 201–208202
Figure 1.3.5: The chemical structures of genipin and geniposide.
The same Genipin has been shown to inhibit hepatocyte apoptosis induced
by transforming growth factor β1, via the interference with mitochondrial per-
meability transition [40], and to protect hippocampal neurons from Alzheimer’s
amyloid β protein toxicity [41]. Genipin was found to possess a significant an-
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tilipoperoxidative, antiinflammatory, and potent antiangiogenic activities. The
latter activity could let genipin be used as adjuvant or combination chemother-
apy for the treatment of cancer [42]. The great advantage of genipin is to be not
only a crosslinker, but it is able also to reduce the inflammatory response of the
engineered tissue upon implantation [43].
As far as genipin crossliking activity, it reacts with primary amino groups
of amino acid or proteins to form dark blue pigments. The mechanism of the
reaction of amino acids or proteins with genipin will be explained later.
1.3.4 Hydroxyapatite
Bone is a complex material composed of nanocrystals of a basic calcium phos-
phate deposited within an organic matrix. The inorganic phase of bone is assimi-
lated to synthetic hydroxyapatite (HA), Ca10(PO4)6(OH)2. HA has the ability to
induce mesenchymal stem cells diﬀerentiation towards osteoblasts [44], whereas
nanosized HA has been found to improve osteoconductivity due to its similarity
with morphology of bone minerals [45]. When implanted in vivo, this material is
non-toxic, antigenically inactive, do not induce cancer and bond directly to bone
without any intervening connective tissue layer. Recent reports on ectopic bone
formation (osteoinduction or material-induced osteogenesis) of calcium phosphate
biomaterials showed that osteoinduction might be an intrinsic property of cal-
cium phosphate biomaterials [46, 47]. The addition of HA in the gelatin/HA
composites has been found to improve the mechanical properties of scaﬀolds and
the activity and viability of rat osteoprogenitor cells cultured on them [48].
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Genipin reaction
Abstract
In this chapter genipin crosslinking reaction will be describe, to optimize the
experimental protocol for scaﬀold manifacturing. Particularly, kinetic constant
and diﬀusion constant have been studied, while mechanism reaction has been
already described in literature. Finally, to establish the degree of crosslinking,
fluorescamine assay ha been performed.
2.1 Introduction
2.1.1 Mechanism reaction
Previous studies [35, 49] have demonstrated that genipin reacts with materials
containing primary amine groups, such as chitosan, gelatin and some peptides
and polypeptides, to form covalently crosslinked networks. It is believed that
the crosslinks are formed via a series of reactions involving diﬀerent sites on
the genipin molecule ending with a radical polymerization responsible of the
blue product. Thanks to radical reactions genipin is able to establish long-
range intermolecular crosslinks, besides intramolecular and short-range inter-
molecular crosslinks respect to the other crosslinkers e.g. 1-ethyl-3-(3-dimethyl
aminopropyl)-carbo-diimide (EDC) and N-hydroxysuccinimide (NHS), or glu-
15
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Figure 3 Schematic illustrations of the crosslinking structures presumed for (a) a fresh gelatin hydrogel (a gelatin
hydrogel without crosslinking), (b) a GP-crosslinked gelatin hydrogel, (c) an EDC-crosslinked gelatin hydrogel, (d)
an EDC/NHS-crosslinked gelatin hydrogel, and (e) an EDC/NHS–GP-crosslinked gelatin hydrogel.
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Figure 2.1.1: Crosslinking structures presumed for (a) a fresh gelatin hydrogel (a
gelatin hydrogel without crosslinking), (b) a GP-crosslinked gelatin hydrogel, (c)
an EDC/NHS-crosslinked gelatin hydrogel.
taraldehyde [50](fig.2.1.1).
The polymerization reaction involves a SN2 nucleophilic substitution reaction
that involves the replacement of the ester group on the genipin molecule by a
secondary amide linkage. This reaction is slower than the other reaction which
must have already formed by the time that the ester substitution occurred. The
reaction scheme begins with an initial nucleophilic attack of the genipin C3 car-
bon atom from a primary amine group to form an intermediate aldehyde group.
Opening of the dihydropyran ring is then followed by attack on the resulting
aldehyde group by the secondary amine formed in the first step of the reaction.
A heterocyclic compound of genipin linked to the residues containing primary
amine groups in gelatin is thereby formed (fig.2.1.2). The formation of blue
pigments suggests that, in addition to these reactions, other more complex reac-
tions occurred. Previous studies of the blue pigments obtained in the reaction
of genipin with amino acids [51] found that they were formed from the oxygen
radical-induced polymerization of genipin and dehydrogenation of intermediate
compounds, following the ring-opening reaction because of attack of genipin by a
primary amine group. The polymerization reactions are induced by the presence
16
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form an intermediate aldehyde group. Opening of
the dihydropyran ring is then followed by attack
on the resulting aldehyde group by the secondary
amine formed in the first step of the reaction. A
heterocyclic compound of genipin linked to the
glucosamine residue in chitosan and the residues
containing primary amine groups in BSA and gel-
atin, via the primary amine group, is thereby
formed. In this study, the immediate increase in
the intensity of an IR band at 1092 cm!1 at the
expense of the 1076-cm!1 band, combined with
the decrease in intensity of the protonated amine
band at 1550 cm!1 upon mixing chitosan and
genipin, is interpreted as the formation of C–N
bonds at the expense of C–O bonds during the
formation of the heterocyclic genipin–chitosan
compound. Because this occurred as soon as the
genipin and chitosan were mixed, this must have
been the first reaction to occur. Additional evi-
dence for the immediate occurrence of this reac-
tion was provided by the immediate decrease in
intensity of the 13C NMR peak that was attrib-
uted to the C3 carbon atom in the genipin mole-
cule and the immediate increase in intensity of
the UV–vis absorption at 280 nm that is believed
to be due to the presence of a heterocyclic geni-
pin–glucosamine/chitosan compound.22 The ne-
cessity for acid catalysis of at least the SN2 ester
substitution reaction and possibly the ring-open-
ing reaction39 explains the much slower rate of
crosslinking in the presence of deuterium oxide.
The constant absorbance of the IR peaks at 1710,
1280, 1155, and 1022 cm!1 justifies their assign-
ment to bonds present in the chitosan or acetic
acid solvent that did not participate in the
crosslinking reaction.
The formation of blue pigments suggests that,
in addition to the reactions involved in crosslink-
ing, other more complex reactions occurred. Pre-
vious studies of the blue pigments obtained in the
reaction of genipin with amino acids found that
they were formed from the oxygen radical-in-
duced polymerization of genipin and dehydroge-
nation of intermediate compounds, following the
ring-opening reaction because of attack of genipin
by a primary amine group.22,34,40,41 The change in
intensity of the 13C NMR peaks due to the genipin
C6, C8, and C10 carbon atoms that were mea-
sured during the reaction provided evidence for
the occurrence of reactions other than those in-
volving the C3 and C11 carbon atoms that were
directly involved in crosslinking. These results
support the suggestion that the polymerization
reactions are induced by the presence of oxygen
radicals because the blue coloration was initially
more pronounced at the interface of the gelled
samples and gradually moved down through the
sample with time. These results also suggest that
the polymerization reactions could only occur
once one of the crosslinking reactions had taken
Figure 18. Crosslinking reactions involving genipin.
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Figure 2.1.2: The fastest crosslinking reaction involving genipin.
of oxygen radicals because the blue coloration was initially more pronounced
at the interface of the gelled samples and gradually moved down through the
sample with time. When the radical reaction starts, genipin molecules react
with one (a dimery) or more genipin molecules before crosslinking with amino
group-containing compounds, so we can explain the long-range intermolecular
crosslinking (fig.2.1.1). Moreover Butler et al. [52] showed that the radical reac-
tion occurs only after that one of the pr vious r actions described take place. No
blue pigments formed when genipin was mixed with acetyl-glucosamine because
it was unable to initiate either of the crosslinking reactions.
The crosslinking genipin reaction is strongly pH dependent. At a high basic
pH, the polymerization of genipin molecules is favoured to link protein chains
distant from each other, but the final product shows a low cr sslinking degree, a
high swelling and high enzymatic hydrolysis rate. While at acid or neutral pH,
genipin can fo maximum a tetrame , so short r links, but with a lower swelling
and enzymatic hydrolysis [53].
2.1.2 Reaction rate constant and order reaction
It is important to know when the reaction between gelatin/collagen and genipin
can be considered ended. On the contrary with the other crosslinkers, genipin
reaction is not so fast, so in this work the reaction has been studied over a
period of 48 hours. Rate equation for a chemical reaction is an equation that
links the reaction rate with concentrations or pressures of reactants and constant
parameters (normally rate coeﬃcients and partial reaction order). For a reaction
aA+bB→pP
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v = k [A]m [B]n
Where k is the reaction rate coeﬃcients that quantifies the speed of a chemical
reaction, it depends on temperature not on reagent or on product concentration.
While m and n are not the stoichiometric coeﬃcients of the balanced equation,
they must be determined experimentally, and they are the order of the reaction
with respect to reagent or product while the sum of m and n is the overall order
of reaction. Reactions may commonly be zero order, first order or second order.
A reaction is zero order when changing the concentration of the reactant has no
eﬀect on the reaction rate. A reaction that is first order has its rate doubled
when the concentration of that reactant is doubled.
v = k [A]
Where doubling the concentration of a reactant results in a quadrupling (x4) of
the rate, the reaction is second order.
v = k [A]2
The order of reaction with respect can be establish from a concentration against
time graph. However, it can sometimes be diﬃcult to decide if a reaction is first-
order or second-order from the concentration-time graph. A rate-concentration
graph quickly reveals the order with respect to a reactant (fig. 2.1.3).
Reactions can also have an undefined reaction order with respect to a reactant.
The common method used to determine the rate equation is the isolation method.
The concentration of one of the reactants remains constant, because it is in great
excess with respect to the other reactants, so its concentration can be included
in the rate constant, obtaining a pseudo constant. If B is the reactant whose
concentration is constant then
v = k [A]m [B]n = k￿ [A]m .
This is the treatment to obtain an integrated rate equation much easier.
18
Chapter 2. Genipin reaction 2.1. Introduction
Figure 2.1.3: (a) Concentration-time graph and (b) rate-concentration graph to
evaluate order reaction.
2.1.3 Diﬀusion coeﬃcient
Diﬀusion, is the thermal motion of all liquid or gas particles at temperatures
above absolute zero. Diﬀusion explains the net flux of molecules from a region
of higher concentration to one of lower concentration, but it is important to
note that diﬀusion also occurs when there is no concentration gradient. Diﬀu-
sive equilibrium is reached when the concentrations of the diﬀusing substance in
the two compartments becomes equal. Molecular diﬀusion is typically described
mathematically using Fick’s laws of diﬀusion.
J = −DdC
dx
(2.1.1)
Equation 2.1.1, is the first Fick’s law that relates the diﬀusive flux J to the
concentration by postulating that the flux goes from regions of high concentration
to regions of low concentration with a magnitude that is proportional to the
concentration gradient. Flux doesn’t change with time, the system is in the steady
state. It is important to determine rate of genipin diﬀusion through gelatin, that
is diﬀusion coeﬃcient, but it is also hard because genipin diﬀusion involves also
a chemical reaction with gelatin. Free diﬀusion through a membrane is linked to
flux definition and Teorell equation. The flux in free diﬀusion can be written in
a form proposed by Teorell (eq.2.1.2)
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Js = ηs · Cs ·∇µs (2.1.2)
where Jsis the flux, that is the numbers of mols of solute crossing one square
meter of membrane per second, and it proportional to the product of ηsthat
is the solute mobility, to Cs that is the solute concentration, and ∇µs is the
driving force of the solute. The choice of a proper driving force is dictated by
thermodynamic considerations by analogy with electrical phenomena. When the
chemical potential of the solute is the same in the two phases bounding the
membrane, the solute is in equilibrium, and its flux across the membrane is zero.
An analogous situation occurs in electrical circuits; when there is no electrical
potential diﬀerence, there is no current flow. When the electrical potentials at two
points are diﬀerent, the potential gradient defines a field, and charged particles
move in response to it. The force acting on the charges is the negative of the
electrical potential gradient. The analogous driving force for solute flux is the
negative of the chemical potential gradient -∇µs. Diﬀusion coeﬃcient D is linked
with its mobility η by the equation 2.1.3:
D = η · R · T (2.1.3)
where R = 8.3144 · J/(mol·K) is the ideal gas constant, T is the absolute temper-
ature. Considering Stokes-Einstein equation for diﬀusion of spherical particles
through liquid (eq2.1.4):
D =
kB · T
6π · νf · r (2.1.4)
where kB = 1.381 · 10−23J/K is the Boltzmann constant, νf is the fluid viscosity,
and r is the particle radius, D depends on the solute dimension particularly on its
radius. Decreasing particle radius, D will increase so the particle transport would
be easier. So using a material with a similar viscosity to gelatin, but unreactive
with genipin could be a method to obtain a real diﬀusion coeﬃcient of genipin.
The material choosen was agarose.
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Figure 2.2.1: Gelatin and gelatin/collagen samples crosslinked with genipin at
diﬀerent concentrations.
2.2 Experimental section
2.2.1 Sample preparation to evaluate reaction rate con-
stant
The rate constant has been studied for the genipin crosslinking reaction with
gelatin alone, and gelatin mixed with collagen. Gelatin type A from porcine skin
was purchased from Sigma-Aldrich (Italy). 5% w/v gelatin solution was obtained
dissolving gelatin in phosphate buﬀered saline (PBS), heating and mixing it to
70°C on a stirrer for 1h till the solute was totally dissolved. Collagen type I
was extracted from rat tail [32] with a 4 mg/ml concentration. Genipin (98% by
HPLC) was purchased from Challenge Bioproducts Co., Ltd (CBC, Taiwan).
A series of samples were prepared mixing 5% w/v gelatin with genipin a
diﬀerent concentration: 2.5%, 2.0%, 1.5%, 1.0%, 0.5%, 0.25%, 0.125% e 0.06%
w/w of the gelatin solution weight. The solutions were stirred to favour genipin
dissolution and let to crosslink in a 24 multiwell plate once at room temperature
and once at 37°C. Other samples were prepared mixing 5% gelatin and 2 mg/ml
collagen solutions in a 1:1 weight ratio (i.e 1g of gelatin with 1g of collagen) and
were crosslinked with the same genipin concentration as above described at room
temperature and at 37°C (fig.2.2.1).
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2.2.2 Image elaboration
To evaluate the rate reaction, the blue pigment formation was considered as an
index of crosslinking progress. The reaction was followed for 48 hours and picture
were taken at established time. Wells from pictures were imported as RGB
matrices in Matlab. The blue component of each matrix, based on the media
value, was extracted after elaboration. Values of the blue intensity were plotted
against time and then they were fitted to obtain the progress of crosslinking
reaction at diﬀerent genipin concentration.
2.2.3 Diﬀusion device
The diﬀusion device is composed of two adjacent sub-chambers separated by
thin removable Teflon divider (S) which contains a thin membrane of gelatin
or agarose, as shown in figure2.2.2. Agarose for routine use was purchased from
Sigma-Aldrich with a gelling point between 34.5°C and 37.5°C. A 1% w/v agarose
solution was prepared in boiling deionized water and allowed to solidify in the
divider hole for membrane. The same experimental setting was followed for
gelatin membrane prepared with a 5% w/v gelatin solution. The large sub-
Figure 2.2.2: Diﬀusion device.
chamber is the liquid chamber containing a 0.5% or 0.25% w/v genipin solution
in 100 ml of PBS, and the small sub-chamber (diﬀusion chamber) contains 10 ml
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of PBS solution. The sub-chamber is 10 cm x 10 cm and 1 cm in height, while
diﬀusion sub-chamber is 5 cm x 2 cm and 1 cm in height. The divider is composed
of three parts as shown in the figure 2.2.3. The first part (A in the figure), has
Figure 2.2.3: Divider composition.
a central hole with a surface of 1 cm2. The second part (B in the figure) is a
thin silicone film, thickness 1 mm, which support membrane and it is put on the
first part A. Finally the third part (C in the figure), is a plexiglass skin put on
the previous two parts to hold them. On A an C, a gauze with big mesh to not
interfere in the measure, is glued in order to confine membrane in the divider.
Thanks to the design of the device some remarks can be made: the ratio 1:10
between volume solutions let the steady state reach quickly; osmotic pressure can
be considered in inverse relation to volume, so it has a low value if the solution
with genipin is in the bigger chamber and diﬀusion in the smaller chamber is
easier. Samples were collected from the diﬀusion chamber at established time
at room temperature, and genipin concentration was evaluated using FLUOstar
Omega spectrofluorimeter (BMG Labtech, Ortenberg Germany) at 244 nm.
2.2.4 Fluorescamine assay
Fluorescamine assay was performed for the quantification of amine groups unre-
acted (￿g/ml) at the end of reaction in order to evaluate the crosslinking degree.
The Fluorescamine protein dye is a fluorescent stain for quantitating minute
amounts of protein and peptides in solution. Fluorescamine is a spiro compound
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that is not fluorescent itself, but reacts with primary amines to form highly flu-
orescent products when activated with UV light (365nm), and with an emission
wavelength of approximately 470nm. The fluorescence of a solution containing
protein or other substance with amino groups, plus fluorescamine is proportional
to the quantity of free amine groups present. It hence has been used as a reagent
for the detection of amines and peptides. 1-100 ￿g of protein and dowm 10 pg
protein can be detected[54]. Samples tested were: 5% gelatin+2 mg/ml collagen
in a 1:1 weght ratio crosslinked with diﬀerent genipin concentration 0.1%, 0.2%,
0.3%, 0.4% w/w. After a casting of 2 days they were freeze-dried for 12 hours. A
fresh stock of 3 mg/ml Fluorescamine solution (Sigma-Aldrich, Italy) was prepar-
ing dissolving it in DMSO. Stock solution was added to about 5 mg of sample
and allow the reaction to incubate at room temperature for 30 minutes. Fluo-
rescence was recorded with FLUOstar Omega spectrofluorimeter (BMG Labtech,
Ortenberg Germany) using BSA (bovine serum albumin) at various known con-
centrations as standard.
2.3 Results
2.3.1 Reaction rate constant
Assuming genipin crosslinking reaction as a first order reaction, and that it oc-
cured in one stage, the general chemical equation is eq.2.3.1:
A+B → P (2.3.1)
its rate equation is:
v = k [A]m [B]n
supposing that B was the reactant in excess respect to A, it can be considered
constant and B can be include in the k value, so k￿ = k [B]n obtaining:
v = k￿ [A]m
24
Chapter 2. Genipin reaction 2.3. Results
where, as supposed to be a first order reaction m=1 and
v = k￿ [A] .
Instant rate equation was
v = −d [A]
dt
= k￿ [A]
multiplying both members by dt[A] and integrating:
[A]ˆ
[A0]
d [A]
[A]
=
tˆ
0
−k￿dt
solving
[A] = [A0] e
−k￿t.
The equation including P concentration was obtained from previous one
[P ] = [A0]
￿
1− e−k￿t
￿
. (2.3.2)
In this case, P represents the polymer formation after genipin reaction which
was blue and its variation can be considered an index of the progress of reaction.
Data obtained from image elaboration were fitted with an equation similar to
equation 2.3.2:
y = (1− e−bx)c+ d (2.3.3)
where b is a time constant so it is the rate reaction constant; c is the final blue
intensity obtained from image elaboration, chemically the product concentration
when reaction ended; d is the initial amount of polymer formed, first blue value.
For a first group of gelatin/collagen samples at diﬀerent genipin concentration,
figure2.3.1, experimental data are showed with standard deviation together with
the curves obtained from equation 2.3.3 after Matlab elaboration.
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Figure 2.3.1: Blue intensity against time as expression of rate reaction, for gelatin
collagen samples at diﬀerent genipin concentration (a)2.5%, (b)2%, (c)1.5%,
(d)1% w/w.
While coeﬃcient obtained from equation2.3.3, that best fit experimental data,
are displayed in table 2.1.
2.5% 2% 1.5% 1% average value standard deviation
b 0.009444 0.009702 0.00877 0.007814 0.0089 0.0008
c 260.5 259 260.1 258.7 259.575 0.00084
d 3.65E-06 2.55E-06 1.73E-06 3.38E-09 1.98234E-06 0.86168
Table 2.1: Coeﬃcients from Matlab elaboration for gelatin collagen and high
genipin concentration.
The rate constant reaction b, is expressed in min-1 with an average value of
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0.0089 min-1 or 1.48·10-3 s-1. At lower genipin concentrations, b showed values
quite diﬀerent from previous ones, so they were grouped a part (fig.2.3.2, and
table2.2). Coeﬃcients for 0.5% genipin reaction were excluded from the average
0.25% 0.125% 0.006% average value standard deviation
b 0.004146 0.003075 0.002784 0.0033 0.0007
c 4.31E-01 4.30E-01 4.85E-01 4.49E-01 0.031
d 0.5493 0.5509 0.5162 0.5388 0.020
Table 2.2: Coeﬃcients from Matlab elaboration for gelatin collagen and low
genipin concentration.
value of table2.2, because they were too diﬀerent respect to the others b=0.13
min-1. The average value b is 3.3·10-3min-1. Blue intensity data from Matlab
image elaboration for 5% gelatin and genipin at diﬀerent concentrations, were
fitted with the same equation2.3.3 table 2.3 , and plotted against time fig.2.3.3.
2.50% 2% 1.50% 1% average value standard deviation
b 0.01195 0.01216 0.01169 0.01086 0.0117 0.0006
c 261.5 260.7 260.9 260.1 260.8 0.5774
d 1.92E-07 4.25E-07 1.49E-06 4.67E-07 6.44E-07 5.79E-07
Table 2.3: Coeﬃcients from Matlab elaboration for 5% gelatin and high genipin
concentration
For this set of experiments the average value b=1.17·10-2 min-1, or 1.95·10-4
s-1. The last group of gelatin samples with lower gp concentration showed the
following graphs fig.2.3.4 and coeﬃcients in table 2.4.
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Figure 2.3.2: Blue intensity against time as expression of rate reaction, for gelatin
collagen samples at lower genipin concentration (e)0.5%, (f)0.25%, (g)0.125%,
(h)0.06%w/w.
0.5% 0.25% 0.125% 0.06% average value standard deviation
b 0.01303 0.0129 0.009 0.009592 0.0111 0.0021
c 0.1379 0.3492 0.4189 0.3045 0.3026 0.1195
d 0.8618 0.6427 0.5435 0.5124 0.6401 0.1579
Table 2.4: Coeﬃcients from Matlab elaboration for 5% gelatin and low genipin
concentration
Average b value is 1.85·10-4 s-1 . In table 2.4 c standard deviation is high it
is because c decays when genipin concentration decreases.
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Figure 2.3.3: Blue intensity against time as expression of rate reaction, for
5% gelatin samples at diﬀerent genipin concentration (i)2.5%, (l)2%, (m)1.5%,
(n)1% w/w.
2.3.2 Static and dynamic diﬀusion coeﬃcient
According to the structure of diﬀusion device (fig.2.2.2), we nominated with D
the coeﬃcient diﬀusion, V1 the bigger chamber volume and C1the concentration
of genipin solution in this chamber, while V2was the smaller chamber volume
(diﬀusion chamber) and C2the concentration of respective genipin solution, L
membrane thickness and A its area. The system followed the first Fick’s law
(eq.2.1.1) in fact it was in a steady state, flux was considered constant within
membrane because it was very thin. The number of particles N which pass
through a unit area in a unit of time, or flux was expressed as:
N = −DdC
dx
=
D
L
(C1 − C2) . (2.3.4)
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Figure 2.3.4: Blue intensity against time as expression of rate reaction, for 5%
gelatin samples at diﬀerent genipin concentration (o)0.5%, (p)0.25%, (q)0.125%,
(r)0.06% w/w.
Molecular number was constant in the system so:
V1C1 + V2C2 + VmCm = constant (2.3.5)
where Vmwas the membrane volume and Cmthe genipin concentration within
itself. Derivatives of members of eq.2.3.5 was zero:
d (V1C1) + d (V2C2) + d (VmCm) = 0. (2.3.6)
Membrane thickness was so small respect to V1 and V2 that we assumed :
V1dC1 = −V2dC2 (2.3.7)
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integrating equation 2.3.7:
C10ˆ
C11
V1 · dC1 = −
C2ˆ
0
V2 · dC2 (2.3.8)
where C10 was the starting concentration of genipin solution and C11 the final
concentration in the bigger chamber. Concentration in the diﬀusion chamber
when experiments started was zero, while final concentration was C2. Solving
equation 2.3.8:
V1C11 − V1C10 = −V2C2 (2.3.9)
and remembering equation 2.3.4
J · A = D −A
L
· (C1 − C2) = −V1 · dC1
dt
= V2 · dC2
dt
(2.3.10)
we obtained molecular number flowing from V1 for second or molecules coming
in V2 for second. From equation 2.3.9 this equation was obtained:
C11 =
V1 · C10 − V2 · C2
V1
(2.3.11)
and replacing it in equation 2.3.10:
D · A
L
·
￿
V1 · C10 − V2 · C2
V1
− C2
￿
= V 2 · dC2
dt
; (2.3.12)
V1C10 − (V1 + V2)
V1V2
DA
L
dt = dC2;
D · A
L
· 1
V1 · V2 · dt =
1
V1C10 − (V1 + V2) · C2 · dC2 (2.3.13)
integrating eq.2.3.13:
tˆ
0
DA
L
1
V1V2
dt =
C2ˆ
0
1
V1C10 − (V1 + V2) · C2 · dC2; (2.3.14)
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D · A
L
· 1
V1V2
· t = 1− (V1 + V2) · [ln (V1 · C10 − (V1 + V2) · C2)− ln (V1 · C10)] ;
−DA
L
V1 + V2
V1V2
t = ln
￿
V1C10 − (V1 + V2)C2
V1C10
￿
;
e
DA·V1+V2
L·V1V2 ·t = 1− (V1 + V2) · C2
V1C10
(2.3.15)
from eq.2.3.15 C2 was deduced and then implemented in Matlab:
C2 =
V1C10
V1 + V2
α ·
￿
1− eDA·V1+V2L·V1V2 ·t
￿
. (2.3.16)
α coeﬃcient was linked to the genipin molecules adsorption on gelatin and agarose
membrane. This phenomenon limits molecules motility through membrane, and
coeﬃcient diﬀusion decreases with time. D in equation 2.3.16 was obtained from
fitting equation. C10, the starting concentration in the big chamber was 5000
￿g/ml or 2500 ￿g/ml. Genipin concentrations in diﬀusion chamber for agarose
and gelatin membrane, collected from spectrofluorimeter were plotted on a graph
versus time fig.2.3.5 and 2.3.6 and fitted with a simplified equation deduced from
equation 2.3.16:
y = α · Ce
￿
1− e−bx￿ (2.3.17)
where Ce is the equilibrium value to which the system tends, b is the same
exponent of equation 2.3.16, x is time and α will be explain later.
b =
A
L
V1 + V2
V1V2
D;
D =
V1V2A
V1 + V2
Lb.
Replacing the experimental volume values and membrane thickness L:
D = 4.5 · 10−6b. (2.3.18)
From equation 2.3.18, replacing b values derived from Matlab (table 2.5 on
the facing page and 2.6 on the next page), we had coeﬃcient diﬀusion D for
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Figure 2.3.5: Genipin concentrations in diﬀusion chambers through 1% w/v
agarose membrane versus time and fitting curve; (a) 0.5% w/v genipin concen-
tration and (b) 0.25% w/v genipin concentration in the bigger chamber.
agarose, static coeﬃcient, and for gelatin, dynamic coeﬃcient.
Agarose membrane
0.25% GP 0.5% GP
α 0.0267 (0.02527, 0.02814) 0.2361 (0.2179, 0.2542)
b 0.8946 (0.5275, 1.262) 0.7442 (0.2947, 1.194)
Table 2.5: Coeﬃcients from Matlab elaboration with its confidence interval for
genipin diﬀusion through agarose.
Gelatin membrane
0.25% GP 0.5% GP
α 0.02165 (0.01972, 0.02357) 0.1994 (0.1813, 0.2175)
b 0.2134 (0.09241, 0.3343) 0.1892 (0.08195, 0.2965)
Table 2.6: Coeﬃcients from Matlab elaboration with its confidence interval for
genipin diﬀusion through gelatin.
Static coeﬃcient, referred to agarose, considers only diﬀusive forces and its
calculated value from equation 2.3.18 and b Matlab coeﬃcient was 3.35·10-6m2/s
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Figure 2.3.6: Genipin concentrations in diﬀusion chambers through 5% w/v
gelatin membrane versus time and fitting curve; (a) 0.5% w/v genipin concentra-
tion and (b) 0.25% w/v genipin concentration in the bigger chamber.
for 0.5% w/v genipin solution and it was 4.02·10-6 m2/s for 0.25% w/v genipin so-
lution. Dymanic coeﬃcient, referred to gelatin membrane, involves the crosslink-
ing reaction between amino groups of gelatin and genipin and its calculated value
was 8.5·10-7 m2/s for 0.5% w/v genipin solution and it was 3.2·10-7 m2/s.
2.3.3 Fluorescamine assay
From calibration BSA curve, we obtained the free amino groups content for ￿g/ml
of gelatin-collagen sample, shown in figure 2.3.7. The last sample with 0.4% w/w
Figure 2.3.7: Free amino groups content at diﬀerent GP concentrations.
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genipin content, resulted fewer in weight respect to other samples after freeze
dryed, so it is not so a relialable value. Increasing genipin content, free amino
groups decreases, it was evident going from 0.1% to 0.2% GP concentrations while
there was not so diﬀerence between 0.2% and 0.3% samples. The crosslinking
reaction with 0.2% GP content can be considered almost ended.
2.4 Conclusions
Genipin crosslinking was characterized regard to rate constant, diﬀusion coeﬃ-
cient and free amino content at the end of reaction. Kinetic data suggested that
after 48 hours, reaction at diﬀerent GP concentrations can be considered com-
pleted, a plateau was reached. We could distinguish two groups for gelatin/collagen
samples with diﬀerent rate constant on the basis of GP concentrations: gelatin/
collagen samples with GP concentrations 2.5%, 2%, 1.5% and 1% showed a higher
rate constant respect to lower GP concentrations 0.5%, 0.25%, 0.125% and 0.06%.
While for gelatin samples rate constant was almost similar for every GP con-
centrations. An explanation could be find considering the diﬀerent molecular
organization between gelatin and collagen. The first is obtained from the denat-
uration of the second, so gelatin shows linear chains with well exposed amino
groups while collagen mantains its globular structure and amino groups are not
so easily reached by genipin. Comparing the static and dynamic coeﬃcient for
both 0.5% and 0.25% GP concentrations, the first resulted bigger, it was because
there was no chemical reactions involved in the diﬀusion process, in fact the
crosslinking of gelatin membrane could prevent genipin diﬀusion. From a deep
analysis of this process we made some remarks. Diﬀusion is a slow process and
in this case after 3 hours the system didn’t reach equilibrium, it was considered
a pseudo-equilibrium. Measuring the GP concentration of both chambers at the
end of the experiment there was a missing genipin weight. Really it was not a
loss but genipin remained trapped in agarose and in gelatin membrane, besides
chemical reaction in the latter one. In agarose membrane there was 4.4% of
genipin trapped when the starting concentration in the big chamber was 0.25%
and 11.8% when concentration was 0.5%, while in gelatin remained 5.7% and
16.8% of genipin starting respectively from 0.25% and 0.5% GP concentration.
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These phenomena are strictly linked with diﬀusion coeﬃcient reduction, and it’s
diﬃcult to find a mathematical model that could explain perfectly this particular
diﬀusion process. Even if rate constant for 2.5% GP concentration is higher, this
concentration revelead toxic for cells and as fluorescamine assay assessed that
there was not so diﬀerence in crosslinking degree when using 0.3% and 0.2% w/w
GP concentration, chosen concentration for preparing samples was 0.2%.
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Scaﬀold preparation and mechanical tests
Abstract
This chapter will deal with the optimal protocol to prepare cartilage and bone
scaﬀolds after selection of suited materials and it will deal with their mechan-
ical characterization, GABO and stress strain tests. Scaﬀold morphology was
evaluated by SEM analysis, while a qualitative-quantitative analysis of materials
distribution was obtained with SEM+EDX analysis. The caracterization starts
with samples with high genipin content 2.5% w/w, thinking that was most im-
portant the gelling time, but later this concentration was found to be over the
toxic genipin value reported in literature. So the genipin content was decreased
till 0.2% w/w and Young’s modulus was measured again. Two protocols for bone
scaﬀolds preparation, both involving ultrasound were compared and increasing HA
content.
3.1 Introduction
Tissue engineering goal is to design a scaﬀold with the same physical character-
istics of tissue to be replaced. Cartilage scaﬀolds have to favour cell adhesion,
to promote cellular colonization throughout the structure preserving its stiﬀness
to mimic native cartilage tissue. Materials chosen in this work are hydrogels,
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they form a three-dimensional network made of hydrophilic polymers able to ab-
sorb water [55]. Poly(ethylene oxide)-dimethacrylate and poly(ethylene glycol)
semi-interpenetrating network, has been proved a good cartilage substitute for
its high water content, its biocompatibility and stifness [56]. Mesenchymal stem
cells seeded onto hydrogel obtained from hyaluronic acid and TGF-β3, produced
more proteoglycans and collagen type II than collagen type I an X [57]. A good
scaﬀold has to be stable till extracellular matrix formation and then it has to
degrade without leaving toxic substances. A bone scaﬀold, has to show mechan-
ical properties suited to the implant site; in vitro its stiﬀness has to be able to
load required weight and it should present a certain porosity degree to let cells
growth, while in vivo the stiﬀness scaﬀold, because bone suﬀers a physiological
stress (compression, torsion and flexion), has to keep tissue intact till its full
regeneration [58]. Surface properties of the scaﬀold aﬀect its bioactivity and os-
teoconductivity. Osteoconductivity is a process that allows osteogenic cells to
migrate onto scaﬀolds thanks to fibrin clot formed after scaﬀold implant. Dur-
ing cell migraton there is a fibrin retraction that may cause detachment. So it’s
important fibrin anchorage and it is favored on rough surface rather than on a
smooth one.
3.1.1 Young’s modulus
For a mechanical characterization, a force or a moment is applied to a sample,
with a precise shape, usually a cylinder or a strip. Force, applied as a compression
or a traction, produces a deformation ￿L without changing sample shape. A
material is called elastic, when a small force is applied and it deforms reversibly,
in other words the material recovers its shape after the force is removed. Usually
there is a limit value of stress, over which deformation becomes irreversible and
material behaviour is called plastic. Young’s modulus is a measure of the stiﬀness
of an elastic material. It is defined as the ratio of the uniaxial stress over the
uniaxial strain in the range of stress in which Hooke’s Law holds. The slope of
the stress-strain curve at any point is called the tangent modulus. The tangent
modulus of the initial, linear portion of a stress-strain curve is called Young’s
modulus. It can be experimentally determined from the slope of a stress-strain
curve created during tensile tests performed on a sample. In anisotropic materials,
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bone is one of them, Young’s modulus may have diﬀerent values depending on the
direction of the applied force with respect to the material’s structure. Young’ s
modulus is also called elastic modulus, and it it the most common elastic modulus
used, but exists other moduli like bulk modulus and shear modulus. Young’s
modulus is the ratio of stress, which has units of pressure, to strain, which is
dimensionless; therefore, Young’s modulus has units of pressure.
3.1.2 Stress-strain curve
The stress–strain curve is a graphical representation of the relationship between
stress, derived from measuring the load applied on the sample, and strain, derived
from measuring the deformation of the sample, i.e. elongation, compression, or
distortion. The slope of stress-strain curve at any point is called the tangent
modulus; the slope of the elastic (linear) portion of the curve is the Young’s
modulus. The nature of the curve varies from material to material. The following
diagram (fig. 3.1.1) illustrates the stress–strain behaviour of typical materials
in terms of the engineering stress and engineering strain where the stress and
strain are calculated based on the original dimensions of the sample and not the
instantaneous values.
Figure 3.1.1: Stress-strain curve: stress σ￿ as function of strain ε. 1) true elastic
limit; 2) proportionality limit; 3) elastic limit; 4) oﬀset yield strength.
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3.2 Experimental section
3.2.1 Scaﬀold preparation
Cartilage scaﬀolds with 2.5% w/w GP
A series of hydrogel constructs with diﬀerent crosslinking agents and realised
with several methods were compared, to asses the best scaﬀold. Hydrogels used
were 5% w/v gelatin type A solution, 2mg/ml collagen type I acid acetic solution,
and 1% w/v agarose aqueous solution previously described. Crosslinking agents
used were besides genipin, EDC/NHS plus DMEM (Dulbecco’s Modified Eagle’s
Medium) culture medium.
Collagen matrix constructs
A set of collagen samples were crosslinked with DMEM culture medium and
0.002 M EDC: 0.05 M NHS solution, and another set with genipin. In the first
method, DMEM was added to the collagen solution in a 1:9 weight ratio and
rested for one hour in order to complete the cross-linking reaction. After that,
the supernatant was removed. DMEM induces a weak collagen cross-linking,
unstable in physiological solution [59]. In fact, the cross-linking reversibility can
be activated increasing the solution pH from 2.9 to basic values. To avoid this
problem, the gel obtained after initial DMEM cross-linking was dipped in 0.05M
EDC : 0.0002 NHS solution for 4 hours. At the end, EDC:NHS solution was
removed and an excess of a 0.1M Na2HPO4 (Sigma-Aldrich, Italy) solution in
water was added for 1 hour to obtain an uniform gel. The resulting collagen
gel was rinsed for 30 minutes in milliQ water to remove all impurities. This
method was adopted to realize cross-linked collagen (CC) constructs. In the
second method, 2.5% (w/w) Genipin, calculated respect to the weight of collagen
solution, was added. The mixture was heated at 40°C under continuous stirring
until the cross-linking process started. This solution was cast on a Petri dish and
rested at room temperature for 48 hours. This method was used to cross-link
both gelatin and collagen.
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Agar matrix constructs
Agar solution in water was used pure or mixed with collagen (crosslinked and
not) in 1:1 weight ratio. The three solutions were casted in 29 mm diameter
Petri dishes, so three samples were realized: pure agar (A), agar and not cross-
linked collagen (ANCC) and agar and cross-linked collagen (ACC) with DMEM
and EDC-NHS. Because agar starts to gel at 45 °C, the collagen was added
to it at around 36 °C, thus avoiding the collagen denaturation. Samples were
hermetically closed to prevent dehydration and stored in fridge at 4 °C.
Gelatin matrix constructs
5% gelatin solution was cross-linked by adding 2.5% (w/ w) GP, respect to the
gelatin solution weight. Three series of samples were realized by casting Gelatin
and GP solution (G), Gelatin and GP solution mixed with not cross-linked colla-
gen (GNCC), and Gelatin and GP solution mixed with pre cross-linked collagen
(GPCC). The GNCC solution was obtained by mixing collagen and gelatin so-
lutions in a 1:1 weight ratio (1g of collagen solution was added to 1g of gelatin
solution) at about 36 °C and adding 2.5% GP, respect to total weight of solution.
GPCC solution was obtained by mixing 1g of gelatin solution to 1g of DMEM
EDC-NHS pre cross-linked collagen and then 2.5% (w/w) GP was added respect
to whole weight of the mixed solution. After 48 hours of casting all samples were
uniform and mechanically stable.
Cartilage scaﬀolds with lower GP concentration
Cartilage scaﬀolds based on 5% gelatin and 2mg/ml collagen were prepared with
lower GP concentration. Samples were prepared mixing 5% gelatin and 2 mg/ml
collagen solutions in a 1:1 weight ratio (i.e 1g of gelatin with 1g of collagen) in
a water bath at 40°C, then GP ad diﬀerent concentration 0.1%, 0.2%, 0.5% w/w
respect to the to total weight of solution was added. The mixture was stirred till
the reaction started, blue appeared. On these scaﬀolds were performed genipin
release test as previous described and gelatin release, while Young’s modulus was
obtained from compression tests conducted using Zwick/Roell mod. Z005 (Zwick
GmbH & Co, Germany).
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Bone scaﬀolds with 2.5% GP content
Agar + hydroxyapatite (AHA) constructs were made by adding 43,7% w/v of
hydroxyapatite (HA) to the 1% w/v agar solution (A), before the beginning
of the gelification process of the latter. Agar + not cross-linked collagen +
hydroxyapatite (ANCCHA) constructs were obtained by mixing 1% w/v agar
solution with not cross-linked collagen solution in 1:1 weight ratio (ANCC) and
then adding 43,7% w/v of HA. Gelatin + GP + hydroxyapatite (GHA) constructs
were obtained by adding 43,7% w/v of HA to the 5% w/v gelatin solution , then
GP was added on the base of the weight of gelatin solution (2.5 % of the weight
of G) to allow the cross-linking process on continuous stirring. Gelatin + not
cross-linked collagen + hydroxyapatite (GNCCHA) constructs were obtained by
mixing the collagen solution with the 5% w/v gelatin solution in 1:1 weight ratio
(GNNCC) on a stirrer in a water bath at about 36 °C and then adding 43,7%
w/v of hydroxyapatite. Then GP was added on the base of the weight of GNCC
solution (2.5 % of the weight of GNCC) to allow the cross-linking process. All
samples are then casted in 29 mm diameter Petri dish for 48 hours.
Bone scaﬀolds with lower GP concentration and higher HA
content
Diﬀerent samples were prepared, varying hydroxyapatite concentration from 30%
to 90% w/v, respect to whole volume of liquid components. For each concentra-
tion, samples were prepared according to two diﬀerent protocols that diﬀer only
in the sonication process, finalized to better fragment and disperse HA crystals
within hydrogel matrix. A Vibra-CellTM (Sonics & Materials, CT, USA) ul-
trasonic probe was used for this purpose. In both cases, the components of the
samples are the following:
• 10% w/v gelatin solution in milliQ water;
• PBS (Phosphate Buﬀered Saline) solution, added in a 1:1 volume ratio,
respect to the gelatin solution volume;
• 2 mg/ml of collagen solution, added in a 2:1 volume ratio, respect to the
gelatin solution volume;
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• HA, properly added in order to obtain composites with HA concentrations
ranging from 30 to 90% w/v, respect to whole volume of liquid components;
• GP, added in a 0.5% w/v ratio, respect to the whole volume of liquid
components.
The first series of samples (protocol 1) were prepared mixing HA powder within
the PBS solution at room temperature, then sonicating this mixture at 0.2W for
2 minutes. 2mg/ml collagen acid acetic solution was added to the gelatin solution
in a 2:1 volume ratio, and finally the previous prepared HA/PBS mixture was
added in a 1:1 volume ratio respect to gelatin solution volume. At the end, GP
was added to all mixture in a 0.5% w/v ratio, respect to the whole volume of its
liquid components. The final mixture was stirred at 40 °C until the beginning of
cross-linking process. The other protocol (protocol 2) provides the sonication of
whole mixture, rather than just HA/PBS ones. So all components were mixed
according to previous ratios and the final mixture was sonicated for 2 minutes
at 0.2 W. In both protocols, samples were left at room temperature either for 48
hours or 10 days.
3.2.2 Collagen release
Collagen released by samples into surrounding aqueous environment was analyzed
with UV spectrophotometry (OMEGAstar - BMG Labtech, Italy). A 2.9 cm
diameter and 4.5 mm height cylindrical sample was completely dipped in a Petri
dish containing 60 ml of deionized water. At diﬀerent times (1m, 2m, 5m, 10m,
15m, 30m, 1h, 2h, 4h, 8h, 24h) 0.5 ml of water bath was sampled and analyzed
at 225 nm with an UV-Vis spectrophotometer.
3.2.3 Genipin Release
Genipin release was performed only for GNNC. Samples with 6 mm diameter and
13 mm height, were put in a test tube containing 10 ml of PBS, mantained at
37°C for 8 days and every day genipin content was analysed with UV spectropho-
tometry at 244 nm.
43
3.2. Experimental section Chapter 3. Scaﬀold characterisation
3.2.4 Swelling tensile stress-strain and creep tests
Tests were performed with the Ugo Basile 7006 isotonic transducer (Ugo Basile,
Italy) connected to the MP35 acquisition platform (BIOPAC Systems Inc, Italy).
The Swelling test allows the evaluation of swelling of a sample dipped in water.
Once the initial length lreal0 was measured, the sample was placed in a Petri
dish and mounted on the transducer, so its deformations were measured. The
sampling rate was fixed at 1 Hz. After one minute of acquisition with no load, the
oﬀset was evaluated and the Petri plate was filled with deionized water until the
sample was completely covered. So, the measured time-dependent deformation
was equal to:
ε (t) =
lreal (t)− lreal0
lreal0
(3.2.1)
where lreal (t) is obtained by adding the oﬀset to the measured length l (t) so it
represents the elongation of the sample at time t. The test was performed until a
stable plateau was reached, so the swelling time constants were derived for each
sample through the analysis of the obtained data. Stress-strain test allows the
assessing of Young modulus of each sample. The sampling time was the same of
the previous test. The weights were applied every 3 minutes, until a maximum
weight of 500g. Elastic moduli were evaluated as stress-strain behavior. Creep
test was performed in aqueous barh after the swelling test on each sample, so as
to have stabilized its original length. In this way the initial length of the sample
was equal to:
lreal0,creep = l
real
0 (1 + εendswelling) (3.2.2)
where lreal0 , is the initial length of sample and εendswelling was the deformation
reached in the plateau area after swelling. The sampling frequency was fixed at 2
Hz. The weight necessary to cause 1% linear deformation of a sample was derived
from its stress-strain graph.
3.2.5 Dynamic loading test
Dynamic loading tests were performed with GABO Eplexor®150N (GABO-
QUALIMETER Testanlagen GmbH, Germany). The elastic modulus in compres-
sion (not the Young modulus obtained from stress-strain tests) can be written
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as:
E∗ = E￿ + iE￿￿
where E￿ is the elastic component (“storage modulus”) and E￿￿ the dissipative
one (“loss modulus”). The transition from the elastic behavior to the beginning
of viscous phenomena can be determined by:
tanδ =
E￿￿
E￿
.
Following parameters were adopted in the setup of experiment:
• Contact force: 0.10 N;
• Static load: one that causes a 2% static strain on the sample;
• Static and dynamic load max forces: 1.50 N;
• Static and dynamic load tolerance: 0.50%;
• Temperature: 25°C;
• Temperature tolerance: 2.00°C;
• Sweep type: log;
• Frequency sweep: 0.1 to 100 Hz (20.67 Hz/dec);
• Number of sampling: 63.
Each sample presents a cylindrical shape with 11 mm diameter and 5 mm height.
3.2.6 Compression stress-strain
Tests were performed using Zwick/Roell mod. Z005 (Zwick GmbH & Co, Ger-
many) controlled in position. Realized samples (6 mm diameter with a thickness
of 13 mm) maintained in PBS were subjected to a compressive load with the
following settings:
• strain rate: 0.07 mm/s;
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• end of loading phase: 10% strain (respect of the initial sample length).
Then elastic moduli were calculated from the first linear tract of stress-strain
curve.
3.2.7 Genipin release
Realized scaﬀolds 6 x 6 mm square with a thickness of 2 mm were dipped in
10 ml of PBS and incubated at 37°C to evaluate release of unreacted genipin.
200 ￿l of soaking solution were daily collected for 7 days and analyzed using an
ultraviolet-visible light spectrophotometer (OMEGAstar - BMG Labtech, Italy)
at 244 nm.
3.2.8 Load unload cyclic tests
Load-unload tests were conducted using Zwick/Roell mod. Z005 (Zwick GmbH
& Co, Germany) controlled in position. Realized samples (6 x 6 mm with a
thickness of 5 mm) were subjected to two consecutive compressive load-unload
cycles at T=25 °C with the following settings:
• strain rate: 0.07 mm/s;
• end of loading phase: 15% strain (respect of the initial sample length);
• end of load-unload cycle: no load.
3.2.9 SEM and SEM-EDX
SEM (Scanning electron microscopy) and SEM-EDX (Scanning electron microscopy-
energy dispersive xray micro-analysis) were performed only on dried samples were
mounted on aluminium stubs and then covered with Au by the Edwards Sputter
Coater B150S equipment. They were observed with a Philips XL20 microscope
(Royal Philips Electronic, Eindhoven, The Netherlands). SEM-EDX is an ana-
lytical technique used for the elemental analysis or chemical characterization of
a sample.
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3.3 Results
3.3.1 Collagen release
Cartilage scaﬀolds and bone scaﬀolds
Spectrophotometric analysis showed that no collagen was released from the scaf-
fold matrix into the surrounding aqueous environment. According to this evi-
dence, no graphs are showed in this paper.
3.3.2 Genipin release
Cartilage scaﬀolds
Considering that genipin toxic concentration tested on osteoblast cultures was es-
tablished to be 80 ￿g/ml [60], biocompatibility could be assessed only for scaﬀolds
crosslinked with 0.2% and 0.1% w/w GP concentrations figure 3.3.1.
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Figure 3.3.1: Genipin release from cartilage subsitutes after 8 days.
Bone scaﬀolds
Results showed that GP released from all samples ranging from 60% to 90%
w/v HA concentrations and crosslinked with 0.5% w/w GP, prepared with two
diﬀerent protocols, were under GP toxic value figure 3.3.2 on the next page.
Respect to cartilage scaﬀolds, bone scaﬀolds with 0.5% w/w genipin concentration
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Figure 3.3.2: GP release from bone scaﬀolds (0.5% w/w GP) after one week,
prepared with two diﬀerent protocols.
were not toxic thanks to sonication introduced in their preparation, that favour
GP reaction crosslinking, so reducing GP unreacted.
3.3.3 Stress-strain test
Cartilage scaﬀolds
From stress-strain graphs (fig. 3.3.3 on the facing page) it is possible to note
that all samples with 2.5% w/w GP content present an elastic behavior. Elastic
moduli of constructs obtained by adding cross-linked or not cross-linked collagen
inside gelatin or agar matrix are lower than those of pure matrices (figure 3.3.4
on the next page). It could be due to the overall steric dimensions of collagen
constructs and not crosslinked collagen included in the polymeric matrix.
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(a)
(b)
Figure 3.3.3: (a) Stress-strain curves of agar matrix samples; (b) Stress-strain
curves of gelatin matrix samples.
Figure 3.3.4: Young’s moduli of agar and gelatin samples with 2.5% GP content.
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Young’s moduli of gelatin samples with 0.2% and 0.5% w/w GP content were
almost equal to 2.5% w/w GP samples one, while 0.1% GP samples had a lower
modulus value as shown in graph 3.3.5. An explanation could be that already
with 0.2% GP content all amino groups were cross-linked, as confirmed by fluo-
rescamine assay in the previous chapter, so increasing GP concentration Young’s
modulus doesn’t change but GP could be only toxic for cells.
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Figure 3.3.5: Young’s moduli of gelatin/collagen samples with lower GP content.
Bone scaﬀolds
The presence of collagen in agar and in gelatin+collagen+2.5% GP in bone sam-
ples with 43.7% HA, results in an increase in the elastic modulus, table 3.1, as
the main eﬀect of collagen in the samples is not to disrupt the network of its
matrix, but to interact constructively with crystals of hydroxyapatite (fig. 3.3.6
on the next page).
Bone scaﬀolds with lower GP concentration and higher HA content
Samples with increasing HA content and lower GP content, realized according
both protocol 1 and 2, were mechanically tested 48h and 10 days after their
preparation. Furthermore, anisotropy was assessed in samples with 30% and
50% w/v HA, applying a load on both their top and lateral surfaces.
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(a)
(b)
Figure 3.3.6: (a) Stress-strain curve for bone sustitutes based on gelatin matrix
and (b) on agar matrix.
48h after preparation Elastic moduli of 60%-90% samples realized accord-
ing to protocol 1 and 2, are shown in fig 3.3.7 on the following page. Samples
prepared using ultrasound to mix only HA and PBS, first protocol, showed a
strange behavior with increasing HA percentage. 60% HA Young’s modulus was
greater than the others, even if going from 70% HA to 90% HA samples, modu-
lus had a linear trend. While samples obtained from second protocol, ultrasound
applied to the whole mixture, showed an almost linear increasing of Young’s mod-
ulus with increasing HA content. Data from these graphs suggested that second
protocol gave a better HA miscibility reflected in a homogeneous trend of Young’s
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sample Young’s modulus (kPa)
43.7%HA+agar 25.95
43.7%HA+agar+collagen 44.80
43.7%HA+gel+2.5%GP 39.35
43.7%HA+gel+coll+2.5%GP 57.45
Table 3.1: Young’s modulus of bone substitute based on agar and on gelatin ma-
trix.
Figure 3.3.7: Young’s moduli for samples after 48h casting, prepared with two
diﬀerent protocols.
modulus and it results bigger than one of protocol 1 for each HA concentration.
Compressive elastic modulus is always greater in the second load-unload cycle es-
pecially due to collapse of internal pores and expulsion of residual. On the basis
of previous results, lower HA concentrations, 30%, 40% and 50% samples were
prepared only with the second protocol. The same trend of higher concentrations
was observed (fig. 3.3.8 on the next page). Mechanical anisotropy was assessed
in samples with 30% and 50% w/v HA realized according protocol 2. Results are
shown in figure 3.3.9 on the facing page.
Similarly to previous results, the elastic modulus increases with the content
of HA and it is always greater in the second cycle. Only the sample with 50%
(w/v) HA showed a marked anisotropy, resulting more rigid in the tangential
direction. This can suggest that there is a threshold HA concentration, above
which the polymeric system shows anisotropy. In figure 3.3.10 on the next page,
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Figure 3.3.8: Young’s moduli for samples after 48h casting, prepared with the
second protocol.
Figure 3.3.9: Young’s modulus for samples after 48h casting calculated in the
normal and tangential direction.
is summarized elastic modulus value for all HA concentrations tested.
Figure 3.3.10: Young’s moduli for all HA concentrations tested after 48h casting
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10 days after preparation Elastic moduli for samples realized according
protocol 1 and 2, are shown in figure 3.3.11. Observations made to discuss pre-
Figure 3.3.11: Young’s moduli for samples after 10 days casting, prepared with
two diﬀerent protocols.
vious results are again applicable. Note that increased time of casting involves
a general tightening of structures, as expected. Studying mechanical anisotropy
in 30% and 50% w/v HA samples (realized according protocol 2) ten days after
their preparation yielded the following results fig. 3.3.12. The increase of the
elastic modulus with HA content and with the second load-unload cycle are con-
firmed. Again, only the sample with 50% (w/v) HA showed a marked anisotropy,
resulting more rigid in the tangential direction. Samples with lower HA content
Figure 3.3.12: Young’s modulus for samples after 10 days casting calculated in
the normal and tangential direction.
were prepared only with the second protocol. They showed (figure 3.3.13 on the
facing page), as previous samples, a homogenous elastic modulus trend.
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Figure 3.3.13: Young’s moduli for samples after 10 days casting, prepared with
the second protocol.
Figure 3.3.14: Young’s moduli of all HA concentration after 10 days of casting.
Values on Y axis are in logarithmic form.
3.3.4 Swelling test
Cartilage scaﬀolds
From the swelling test analysis, table 3.2, it is possible to note that samples that
have gelatin as a matrix did not present swelling. This was due to a complete
cross-linking of gelatin that created a structure that was not permeable to aqueous
solutions. Instead, samples with agar matrix presented a low swelling relaxation.
The swelling was due to the porous structure of the agar matrix and to the
presence of CC and NCC which increased the dimension of these pores, and
allowed water perfusion within the structure. This hypothesis was confirmed by
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sample final swelling strain (%) relaxation time (s)
CC 4 2000
A 2.4 8000
ANCC 1.5 1500
ACC 3 1000
G 0 ∞
GNCC 0 ∞
GPCC 0 ∞
Table 3.2: Swelling results for CC(crosslinked collagen), A(agar),
ANCC(Agar+not crosslinked collagen), ACC(agar+crosslinked colla-
gen), G(gelatin+GP), GNCC(gelatin+not crosslinked collagen+GP),
GPCC(gelatin+pre crosslinked collagen+GP).
reduced relaxation times in samples which embed CC.
Bone scaﬀolds
We did not observed appreciable swelling in aqueous environment for any sample.
As example, figure 3.3.15 shows the swelling behavior of 60% HA protocol 1, and
it is possible to note only noise centered around zero.
Figure 3.3.15: Gelatin+collagen+0.5%GP+60% HA sample swelling.
56
Chapter 3. Scaﬀold characterisation 3.3. Results
CC A ANCC ACC G GNCC GPCC
k1(kPa) 5.05 32.26 9.68 7.23 101.22 86.16 90.09
k2(kPa) 2.71 14.13 6.42 5.39 157.50 75.50 54.22
η (kPa·s) 83.95 158.39 74.21 144.07 2148.30 17667.00 13934.54
τ (s) 30.98 11.21 11.56 26.73 13.64 234.00 257.00
Table 3.3: Calculated coeﬃcients for cartilage creep test.
3.3.5 Creep test
Cartilage scaﬀolds
The tested materials showed a mechanical behavior describable with the Kelvin
model, expressible as:
ε = εspring + εV oigt =
σ0
k1
+
σ0
k2
￿
1− e−tτ
￿
. (3.3.1)
This model fits very well with the obtained experimental data (fig. 3.3.16 on the
following page). From table 3.3, it is possible to note that the elastic constants
(k1, k2) are similar to the experimental elastic moduli. It is possible to note that
the elastic constants (k1, k2) are similar to the experimental elastic moduli. In
addition, samples with agar matrix show a short creep time due to the large water
content within them. The presence of cross-linked and not cross-linked collagen
produces a considerable increase in viscosity η. This fact could be explained by
the theory of “recruitment of the fibers” [61]. Collagen fibers are arranged in
a complex structure, thus their alignment along the direction of traction is a
slow and gradual process which results in an increase in viscous behavior. This
aspect explains why samples with gelatin matrix have the highest constant of
viscosity (and longest characteristic creep time) when collagen was embedded in
them respect to pure cross-linked gelatin.
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Figure 3.3.16: Creep experimental data with fitting curve for CC(crosslinked col-
lagen), A(agar), ANCC(Agar+not crosslinked collagen), ACC(agar+crosslinked
collagen), G(gelatin+GP), GNCC(gelatin+not-crosslinked collagen+GP),
GPCC(gelatin+pre-crosslinked collagen+GP).
Bone scaﬀolds
Also these materials showed a mechanical behavior similar to the Kelvin model
equation 3.3.1, this model fitted very well the experimental data obtained fig. 3.3.17
on the next page. The obtained results are summarized in table 3.4 . If compared
with stress-strain data, it is possible to note similarities between the elastic con-
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stants values (k1 and k2 ) and the experimental elastic moduli (Young’s moduli).
The presence of hydroxyapatite led to a much more compact structure charac-
terized by a predominantly elastic behavior, so the results show low viscosity
constants and, consequently, a relatively short characteristic creep time.
Figure 3.3.17: Creep test with fitting curve for ANCCHA (agar+not-
crosslinked collagen+43.7%HA) and GNCCHA (gelatin+not-crosslinked colla-
gen+2.5%GP+43.7%HA).
3.3.6 Dynamic loading test
Cartilage scaﬀolds
All samples demonstrated a marked increase in the compression modulus with
increasing deformation rate. At high-speed deformation samples have an elastic
behavior, while for low-speed deformation their behavior is similar to a viscous
liquid. This trend in compression modulus is justified because polymeric chains
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ANCCHA GNCCHA
k1(kPa) 482.50 163.95
k2(kPa) 73.82 41.58
η (kPa·s) 349.91 349.91
τ (s) 4.74 4.37
Table 3.4: Calculated coeﬃcients for bone subsittutes creep test.
could not orient along the loading direction because of the increase in the fre-
quency of stimulation. Viscous behavior involves inner flows of polymeric chains
which is associated with the conversion of mechanical energy into heat, so the
temperature rises. For all samples there is a nearly perfect overlap between
the “storage” and the overall modulus. For this reason the samples principally
present an elastic behavior and, therefore, losses due to viscosity are very limited.
The “loss” modulus is significantly lower than the “storage” one in the consid-
ered frequency range, and, consequently, tan(δ), the ratio between the “loss” and
“storage” modulus, is close to zero. Tan (δ), “loss” and “storage” modulus, are
shown for cross-linked collagen and for agar-matrix samples in the 0-10 Hz fre-
quency range fig 3.3.18 on the facing page. Tan (δ) is stable at about 0.1 already
at a frequency of 1 Hz, that is the typical frequency value corresponding to nor-
mal walking. This result suggests that all samples present an elastic mechanical
behavior.
3.3.7 SEM micrographies
Cartilage scaﬀolds
At 1000x magnification, SEM Micrograph (figure 3.3.19 on page 65) a) shows
gelatin fibers cross-linked by genipin. At minor magnification the matrix appears
compact. The morphology of GPCC construct is compact and non regular due to
protein aggregates ( fig3.3.19 b-c). This confirms the mechanical and the swelling
results. At high magnification it is possible to note a morphology close to that
observed for cross-linked gelatin (fig.3.3.19 d-e).
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Figure 3.3.18: Dynamic loading curve of (CC) Cross-linked collagen; (A) Agar;
(ANCC) Agar and not cross-linked collagen; (ACC) Agar and cross-linked colla-
gen.
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Bone scaﬀolds
Surface roughness, observable even at low magnification, is associated with the
presence of hydroxyapatite (fig. 3.3.20 a). At higher magnification it is possible
to see HA crystals coated and interconnected by gelatin and collagen fibers (fig.
3.3.20 b-c). This evidence confirms the hypothesis that collagen acts as a glue
linking together hydroxyapatite crystals.
Figure 3.3.20: SEM micrographs of (a) GNCCHA (gelatin+not-crosslinked col-
lagen+2.5%GP+43.7%HA) at 35x magnification; (b) at 250x magnification and
(c) at 1000x magnification.
3.3.8 SEM-EDX
This non-destructive technique allows the analysis of solid samples that are stable
under the operating conditions of low pressure and electron bombardment. EDX
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analysis of constructs indicates a uniform distribution of calcium (red in figure
3.3.21) and phosphorus (green in figure 3.3.21). The quantities of the elements,
given as weight percentages, are Calcium = 70.28%, Phosphorous = 26.78 % and
Magnesium = 2.94%.
Figure 3.3.21: SEM-EDX for bone sustitute gelatin+not-crosslinked colla-
gen+2.5%GP+43.7%HA.
3.4 Conclusions
All scaﬀolds characterisation can be divided in two experimental parts. In the
first part, the genipin concentration used, 2.5% w/w, was decided favouring the
rate reaction, but after genipin release assessment this concentration revelead
to be toxic for cells. So scaﬀolds with lower GP concentrations were tested first
measuring its release in acqueous enviroment, and then evaluating Young’s modu-
lus. As regard cartilage substitutes, reduced GP concentration, till to 0.2% w/w,
didn’t aﬀect elastic modulus, and scaﬀolds could re-enter in the biocompatibility
range starting from 0.2% GP and going down. While for bone substitutes biocom-
patibility was already assessed with 0.5% GP concentration, thanks to sonication
included in the protocol preparation to improve HA miscibility, especially when
HA was present in higher concentrations. Ultrasound were introduced at two
diﬀerent levels giving two diﬀerent protocols. The best was the protocols includ-
ing sonication of the entire mixture, that showed a homogeneous trend of elastic
modulus. Meanwhile collagen release was absent and also swelling, showing sta-
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bility of these structure. All experimental results suggested that 5% w/v Gelatin
+ not crosslinked collagen 1:1 + 0.2% GP constructs could be used as an innova-
tive hydrogel for cartilage repair. The elastic modulus of the constructs does not
mimic that of natural tissue, but their high biocompatibility and the presence
of chemo-attractors within them should help to produce fast cell colonization.
Adding HA at diﬀerent concentrations respect to gelatin collagen mixture vol-
ume we can modulate elastic modulus on the basis of our needs, considering
that Young’s modulus of cancellous bone is 0.02-0.5 GPa. From SEM analysis,
structures present an uniform distribution of calcium and phosphorous, and HA
crystals are interconnected each other by gelatin and collagen. These results
suggest that these scaﬀolds were suitable substitutes for bone regeneration.
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Figure 3.3.19: SEM micrographs of (a) Gelatin (1000x magnification); (b)
Genipin and not cross-linked collagen (35x magnification); (c) Genipin and not
cross-linked collagen (250x magnification); (d) Genipin and not cross-linked col-
lagen (500x magnification); (e) Genipin and not cross-linked collagen (1000x
magnification).
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Discrete graded bone scaﬀolds
Abstract
In the previous chapter the optimal protocol to prepare bone scaﬀolds was fixed,
here the realization of discrete bone scaﬀolds and their mechanical characteriza-
tion will be described. Moreover, scaﬀold response to diﬀerent pH will be tested,
both for discrete and homogeneous scaﬀolds.
4.1 Introduction
4.1.1 Gradients in natural structures
The structural organizations found in nature are largely dictated by their func-
tions, load-bearing function, biomechanical function, etc. Simple observations of
natural tissues and organs show that these structures are not homogeneous and
there exist natural functional gradients in their structure, as seen in the examples
of bamboo, mollusc shells and human tissues such as bone and skin [62]. When
each layer of the tissue or organ has one or more specific functions to perform
and the tissue or organ has more than one layer, the tissue or organ is said to be
functionally graded across the layers. Simply, the tissue or organ is described as
functionally graded. As such, to regenerate the natural tissue, a successful TE
scaﬀold should also be functionally graded. This is to facilitate the seeded cells
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to proliferate at the desired layer and to perform their functions properly and
normally to achieve the regeneration of healthy tissues. This can be observed
and described from three perspectives: biological, mechanical and anatomical.
Matching these perspectives will provide the favourable environment required for
cell growth and proliferation for successful organ or tissue regeneration. From
a biological point of view, functional gradients are very often observed in hu-
man organs and tissues. Diﬀerent layers of the tissue perform diﬀerent roles in
maintaining the organ functions. One layer may possess cell types or phenotypes
that may be diﬀerent from other layers. A well-engineered TE scaﬀold should be
tailored with the appropriate pore sizes and porosities according to the needs of
the specific cells to better accommodate the proliferation and growth of the cells.
To drive the neo-tissue to behave like the original tissue, some kinds of mechan-
ical cues are needed [63]. Human bone, observed across its transverse section,
has a graded structure varying its pore size and porosity distribution. Its outer
layer, cortical bone, is solid and dense, while the inner layer, cancellous bone, is a
spongy honeycombed structure filled with blood vessels and bone marrow maxi-
mizing the strength to weight ratio for bending and compression loads [62]. As a
result, bone structure has functionally graded mechanical properties. Mechanical
properties of scaﬀold should match those of the host tissue, this is particularly
important for bone tissues as they are the main load-bearing tissues in the body.
For a load-bearing tissue, if the scaﬀold has superior mechanical properties as
compared to those of bone, the scaﬀold will take the load previously taken by
the bone and thus shield the bone from load, causing bone resorption at the sur-
rounding tissue. The opposite scenario of having an inferior scaﬀold will result
in scaﬀold failure, as the scaﬀold does not have suﬃcient strength to withstand
the physiological loads [64].
4.1.2 pH during fracture healing
During healing process there is a relevant pH change as shown in figure 4.1.1 on
the next page. Cells damage togheter with lactic acid turn pH to acid value.
Slowly after 10 days pH rises to physiologic and then reaches basic value when
phosphatase activity, responsible for the hydrolysis of esters of phosphoric acid,
becomes intense. Maximum basic value is reached after 25 days when mineral
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Figure 4.1.1: pH variation during healing fracture.
salts starts to precipitate and slowly it returns to neutral pH. These are indicative
values and times they depend on subjects. The remodeling process begins at a
quiescent bone surface with the appearance of osteoclasts. These are large mult-
inucleated cells that form by fusion of mononuclear precursors of haemotopoetic
origin [65]. They attach to the bone tissue matrix and form a ruﬄed border at
the bone/osteoclast interface that is completely surrounded by a “sealing” zone.
Thus the osteoclast creates an isolated microenvironment. Subsequently the os-
teoclast acidifies the microenvironment and dissolves the organic and inorganic
matrices of the bone [66]. Briefly after this resorptive process stops, osteoblasts
appear at the same surface site.
4.2 Experimental section
4.2.1 Homogeneous and discrete graded samples prepara-
tion
Homogeneous scaﬀolds were prepared according to protocol 2, described in the
previous chapter, with 30%, 40%, 50%, 60%, 70%, 80% and 90% HA w/v con-
centrations followed by 48h or 10 days casting. Discrete graded scaﬀold were
realized stacking mixtures with diﬀerent HA concentrations, obtained as previ-
ously described. Precisely, four diﬀerent discrete gradient samples were realized,
stacking diﬀerent homogeneous layers characterized by following HA concentra-
tions (both 48h and 10 days casting samples): 30-50%, 60-70%, 80-90% and a
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multilayer 30%-40%-50%-60% sample (only after 48h from preparation). The
genipin cross-linking process was used to join the diﬀerent layers. First, the bot-
tom layer with desired HA concentration was prepared, than the second layer
(with a lower HA concentration) was cast on it only when genipin cross-linking
process started, thus avoiding mixing between layers and allowing, at same time,
a parallel cross-linking completion that joins the two diﬀerent layers.
4.2.2 Buﬀer solution preparation
Buﬀer solution pH 5 was an acetate buﬀer prepared using acid acetid and sodium
acetate salt; pH 6 buﬀer solution was made of hydrogen phthalate/hydrogen ph-
thalate anion, pH 8 was a phosphate buﬀer made of sodium dihydrogen phos-
phate/dipotassim phosphate. PBS was pH 7 buﬀer.
4.2.3 Load-unload cyclic tests
Discrete samples were mechanically tested both 48h and 10 days after their prepa-
ration for anisotropy, and homogeneous scaﬀolds were tested dipped in diﬀerent
buﬀer solution with pH values 5, 6, 7, 8. Parameters and instrument used were
the same of previous chapter: Zwick/Roell mod. Z005 (Zwick GmbH & Co, Ger-
many) controlled in position. Realized samples (6 x 6 mm with a thickness of 5
mm) were subjected to two consecutive compressive load-unload cycles at T=25
°C with the following settings:
• strain rate: 0.07 mm/s;
• end of loading phase: 15% strain (respect of the initial sample length);
• end of load-unload cycle: no load.
4.3 Results
4.3.1 Cyclic compression tests on discrete gradient samples
According to figure 4.3.1 on the facing page, layers react in series when the load
is applied in the normal direction (versor n in figure), while they react in parallel
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when construct is subjected to a tangential load (versor t in figure). Results
for discrete gradient scaﬀolds are shown as for previous composite homogeneous
samples after 48h and 10 days casting.
Figure 4.3.1: Load application to discrete scaﬀolds.
48h after preparation Elastic moduli for bi-layered structures are shown in
the following figure 4.3.2 on the next page. Only 30%-50% HA discrete gradient
sample showed a marked anisotropy, as their two layers react in series or in
parallel to the load, depending on its direction of application. Results confirmed
that compressive modulus increases as HA total concentration increases and it
is always greater in the second cycle for both loading directions. Furthermore,
discrete gradient structures were more rigid when their layers are subjected to
a tangential load. This evidence was more pronounced within the second cycle,
since both layers were stiﬀ due to residual water expulsion and collapse of internal
pores. Also multilayer scaﬀold (figure 4.3.3) showed anisotropy with a bigger
elastic modulus for tangential direction after one compression cycle.
Figure 4.3.3: Elastic modulus of multilayer scaﬀold after one compression cycle.
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Figure 4.3.2: Elastic moduli (after 48 hours from preparation) of discrete gradient
scaﬀolds made by homogeneous samples.
The tested materials showed a mechanical behavior describable with the
Kelvin or Reuss models depending on the direction of load application (fig-
ure 4.3.4 on the next page). In the Voigt model, the overall Young’s modulus
Ecomposite of the composite with two constituents 1 and 2 in the specified load
direction is given by:
Ecomposite = E1V1 + E2V2 (4.3.1)
where E is elastic modulus and V is volume fractions of single layer. This model
provides an upper bound to the composite stiﬀness. A lower bound is given by
the analogous Reuss model which yields:
Ecomposite =
E1E2
V1E2 + V2E1
(4.3.2)
Young modulus obtained from the equations for 30%-50% HA sample, were
similar to experimental ones for 48h casting (table 4.1). Elastic modulus eval-
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che tangenziale. Tale risultato sembra a prima vista rispettare il modello di Reuss e
Voigt applicato ai materiali compositi, che sarà illustrato nel prossimo paragrafo.
3.3.4 Valutazione modello meccanico
I campioni a gradiente discreto possono essere visti come compositi prodotti dalla
deposizione di quattro diversi strati che, secondo la modalità di applicazione del
carico durante la prova di compressione, possono mostrare una configurazione Reuss
o Voigt. Può risultare utile applicare i relativi modelli di calcolo del modulo elastico
come elemento predittivo del comportamento meccanico del materiale a gradiente
essendo note le caratteristiche meccaniche delle parti che lo compongono.
Figura 3.20: Configurazioni Voigt Reuss
Configurazione Reuss La configurazione di Reuss implica che le parti sovrap-
poste del composito sono sottoposte allo stesso carico σ. Il sistema è quindi in
condizione di isosforzo. La situazione quindi è analoga a quella in cui i campioni
venivano compressi lungo la direzione z.
L’allungamento del composito invece, sarà dato dalla somma degli allungamenti
dei costituenti. Indicando con f la frazione volumetrica (volume del componente
su volume complessivo del composito), in questo caso uguale per tutti gli strati ed
E1,E2,E3,E4 i moduli elastici delle singole parti si ha che:
1
Ecomposito
= f1E1 +
f2
E2
+ f3E3 +
f4
E4
poichè f1 = f2 = f3 = f4 = f = 0, 25 si ha che il modulo elastico totale è:
Ecomposito =
E1E2E3E4
f(E2E3E4+E1E3E4+E1E2E4+E1E2E3
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Figure 4.3.4: Voigt and Reuss models.
EReuss EVoigt Exp EReuss Exp EVoigt
first cycle (kPa) 36.00 46.8 45.70±8.46 88.60±32.90
second cycle (kPa) 71.3 100.00 95.60±14.90 151.00±46.00
Table 4.1: Experimental and calculated elastic moduli for 30%-50% HA sample
after 48h casting.
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uated for multilayer samples using equations 4.3.1and 4.3.2, and experimental
moduli showed in table 4.2 were similar.
EReuss(kPa) 62.84 Exp EReuss(kPa) 57.8±9.6
EVoigt(kPa) 132.27 Exp EVoigt(kPa) 123±6.5
Table 4.2: Experimental and calculated elastic moduli for multilayer HA sample
after 48h casting.
10 days after preparation These samples showed an inverse trend respect to
HA increasing content. Elastic moduli decreases with increasing HA and 60%-
70% sample didn’t show anisotropy (figure 4.3.5). We can suppose that HA
undergoes a diﬀerent rearrangement after water evaporation that leds an irregu-
lar elastic modulus trend. For these samples, there no similarity with calculated
Figure 4.3.5: Elastic moduli (after 10 days from preparation) of discrete gradient
scaﬀolds made by homogeneous samples.
and experimental moduli, using Reuss-Voigt equation, due to their strange ex-
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perimental behavior (table 4.3).
EReuss EVoigt Exp EReuss Exp EVoigt
first cycle (MPa) 15.8 12.30 75.40±11.30 26.7±11.50
second cycle (MPa) 26.10 29.3 131.00±14.4 54.40±5.94
Table 4.3: Experimental and calculated elastic moduli for 30%-50% HA sample
after 10 days casting.
4.3.2 Elastic modulus at diﬀerent pH
48h casting At same pH compressive elastic modulus basically increases as
content of HA increases. It increases with increasing pH, it is more evident in
high HA samples (fig. 4.3.6). It is because HA, basic material, dissolves at acid
pH, so elastic modulus decrease. At same time genipin reaction is favoured at
slow basic pH [53], and it gives a higher modulus.
Figure 4.3.6: Elastic moduli trend at diﬀerent pH for 48h casting sample.
10 days casting Homogenoous scaﬀolds after 10 days had the same trend
of 48h casting samples (fig. 4.3.7 on the following page). As aspected Young
modulus is greater after water evaporation respect to 48h samples.
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Figure 4.3.7: Elastic moduli trend at diﬀerent pH for 10 days casting sample.
4.4 Conclusions
In this chapter we considered a particular situation that occurs after bone trauma,
that is a change in pH value. Elastic moduli of homegenous bone scaﬀolds rang-
ing from 30% HA to 60% HA were meseaured at diﬀerent pH (5, 6, 7 and 8)
observed during fracture healing. All samples were prepared with the second
protocol and tested after 48h and 10 days dipped in diﬀerent buﬀer solutions.
An increasing pH aﬀected positively Young’s moduli both because HA was less
soluble in basic conditions, both because genipin could improve long range link-
ing. These behavior was more evident with 60% HA content. Another important
bone feature considered in this chapter was its mechanical gradient. A series of
discrete gradient scaﬀolds, three bi-layered and one multilayered, were realized
and tested for anisotropy. Only 30%-50% and multilayered HA scaﬀolds showed
anisotropy after 48h of casting, while all 10 days casting samples had an anoma-
lous tendency, reﬀered to a possible HA rearrangement during water evaporation.
Elastic modulus of tangential direction was bigger than assial one, as happens in
bone. So these are good candidates for bone substitutes, particular multilayered
scaﬀold.
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In vitro tests
Abstract
This chapter will deal with preliminary biocompatibility in vitro tests for cartilage
and bone substitutes characterized in previous chapters. Primary murine fibrob-
lasts were seeded on cartilage scaﬀolds and cells viability was analyzed via Alamar
assay togheter with DAPI staining, the last only to furnish qualitative data. Bone
scaﬀolds were seeded with MG63 cells (Human osteosarcoma cell line) and cells
adhesion and proliferation were observed under SEM.
5.1 Introduction
5.1.1 Genipin biocompability
Genipin, a compound extracted from the fruit, is a traditional medicine for dia-
betes and raw material for pigment production. Its great potential as a natural
crosslinking agent for biomaterials was first reported in 1998: in comparison with
glutaraldehyde, genipin exhibited comparable crosslinking capability but signif-
icantly lower toxicity. Genipin was first tested to fix biological tissues and glu-
taraldehyde and an epoxy compound (ethylene glycol diglycidyl ether) were used
as controls. It was found that the genipin-fixed tissue had a resistance against
enzymatic degradation comparable to the glutaraldehyde-fixed tissue. This sug-
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gested that genipin can form stable crosslinked products [67]. In addition, the
biocompatibility of the genipin-fixed tissue was studied in a growing rat model
subcutaneously [68]. It was noted that the inflammatory reaction of the genipin-
fixed tissue was significantly less than its glutaraldehyde- and epoxy-fixed coun-
terparts. The cytotoxicity of genipin was previously studied in vitro using 3T3
fibroblasts, glutaraldehyde was used as a control [35]. The results obtained in
the MTT assay implied that genipin was about 10,000 times less cytotoxic than
glutaraldehyde. Also, the colony-forming assay suggested that the proliferative
capacity of cells after exposure to genipin was approximately 5000 times greater
than that after exposure to glutaraldehyde. It was noted that the 3T3 fibroblasts
seeded on the surface of the glutaraldehyde-fixed tissue were not able to survive.
In contrast, the surface of the genipin-fixed tissue was filled with 3T3 fibrob-
lasts. In addition, neocollagen fibrils made by these fibroblasts were observed
on the genipin-fixed tissue. Residues from the genipin-fixed had no toxic eﬀect
on the seeded cells while those released form glutaraldehyde-fixed tissue reduced
cells population. This indicated that the cellular compatibility of the genipin-
fixed tissue was superior to its glutaraldehyde-fixed counterpart. Furthermore a
GP-crosslinked gelatin hydrogel is less cytotoxic than a carbodiimide-crosslinked
gelatin hydrogel [50]. Cells cultured in the medium containing the fresh sample
and in the vicinity of the GP-crosslinked gelatin hydrogel were confluent. In
contrast, the cells cultured in the vicinity of the EDC-, EDC/NHS-crosslinked
gelatin hydrogels were not as confluent.
5.2 Experimental section
5.2.1 Scaﬀold sterilization
All scaﬀolds, cartilage and bone ones, were prepared with protocols explained in
chapter 3. Cartilage scaﬀolds tested were 5% gelatin+2mg/ml collagen 1:1 with
0.2% w/w genipin, while bone scaﬀolds, besides the same concentrations and ratio
of gelatin and collagen, had 0.5% w/w Genipin and diﬀerent HA concentration
that goes from 22,5% to 90% w/v of entire mixture. Collagen and gelatin and
all instruments were sterile, preparation was carried out in a laminar flow hood.
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About 250 µl of mixture was put in a 24 well plate and then in a humidified
incubator at 37°C, using a standard mixture of 95% air and 5% CO2 for two days
to complete crosslinking. After casting scaﬀolds were washed with EtOH 70%,
PBS, and finally exposed to UV for 30’ to be sure to sterilize them. The scaﬀolds
were pre-wetted in the culture medium overnight before seeded.
5.2.2 Cell culture and seeding
Cartilage scaﬀolds A vial of cryopreserved fibroblast primary murine cells
was thawed and plated and cultered with Dulbecco’s modified Eagle’s medium
4.5 g/l glucose (Lonza, Milan, Italy) supplemented with 10% fetal bovine serum
(FBS), 1% L-glutamine (Lonza, Milan, Italy), and 1% Penicillin-Streptomycin-
Amphotericin B Mixture (Lonza, Milan, Italy). They were grown in a controlled
atmosphere (5% CO2; T=37°C) and at confluence they were split 1:6 and used at
five passage. Cells were detached using 0.25% trypsin (Lonza, Milan, Italy) and
seeded (in triplicate) onto scaﬀolds and in wells coated with a mixture 1:1 of 5%
gelatin+ 2mg/ml collagen as controls at a density of 1 × 104cells/cm2. Scaﬀolds
(in triplicate) only with media culture, without cells, were used as blank. They
were cultured for 3 days.
Bone scaﬀolds MG-63 human osteoblast-like cells (ATCC, Rockville, MD)
were grown in a controlled atmosphere (5% CO2; T=37°C) in Dulbecco’s modified
Eagle’s medium 4.5 g/l glucose (DMEM; Sigma, Milan, Italy) supplemented with
10% fetal bovine serum (FBS), 1% L-glutamine (Sigma), and 1% antibiotics
(penicillin–streptomycin; Gibco-Invitrogen, Milan, Italy). After thawing, they
were routinely split 1:10 every 2–3 days. MG-63 cells were detached using 0.25%
trypsin in 1 mM EDTA (Sigma) and seeded (in triplicate) onto scaﬀolds at a
density of 1× 104cells/cm2. They were cultured for 2 days.
5.2.3 Alamar blue assay
After seeding, Alamar blue assay, cell viability assay, (The CellTiter-Blue®„
Promega, Italy) was performed every day to asses cartilage scaﬀold biocompati-
bility. Alamar assay provides a homogeneous, fluorometric method for estimat-
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ing the number of viable cells. It uses the indicator dye resazurin to measure
the metabolic capacity of cells, an indicator of cell viability. Viable cells re-
tain the ability to reduce resazurin into resorufin, which is highly fluorescent
(579Ex/584Em). Nonviable cells rapidly lose metabolic capacity, do not reduce
the indicator dye, and thus do not generate a fluorescent signal. The fluorescence
produced is proportional to the number of viable cells. The medium was removed
from all samples (including controls and blanks) and replace with fresh one, then
Alamar solution was added in an amount equal to 10% of the culture medium
volume according to the manufacturer’s instructions. Aliquots were transferred
to a 96-well plate after 30’ and 2h 30’, and the fluorescence was recorded us-
ing spectrofluorimeter (OMEGAstar - BMG Labtech, Italy). The viability was
expressed as percent fluorescence of samples respect to controls.
5.2.4 DAPI staining
At the end of third day, cells were immediately fixed in 10% formaldehyide in PBS
for ten minutes and stained with DAPI (4’, 6-diamino-2-phenyldione) (Sigma, Mi-
lan, Italy) for 5 minutes and observed under a fluorescence microscope. DAPI
can pass through an intact cell membrane and binds strongly to A-T rich re-
gions in double stranded DNA. For fluorescence microscopy DAPI is excited with
ultraviolet light and is detected through a blue/cyan filter.
5.2.5 SEM and SEM-EDX
SEM and SEM-EDX were performed only for bone scaﬀolds at the end of two
days MG63 culture. Samples were fixed in 2% glutaraldehyde (Sigma) in 0.1M
cacodylate buﬀer (pH 7.4, Sigma), postfixed in 1% osmium tetroxide (Sigma),
dehydrated in increasing ethanol (Sigma) concentrations, CPD (critical point
drying)-dried, mounted on aluminium stubs, and gold-sputtered with the Ed-
wards Sputter Coater B150S equipment. They were observed with a Philips
XL20 microscope (Royal Philips Electronic, Eindhoven, The Netherlands).
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5.3 Results
5.3.1 Cell viability
In figure 5.3.1 fibroblast viability after 3 days is showed. Viability of fibroblasts
seeded on scaﬀolds, expressed as percent fluorescence respect to fibroblasts seeded
on well coated with gelatin collagen (control), was inferior to 50% during the first
day, but then it raised during the second days to reach control value at the end of
experiment. During the third day there was a small decrease in control viability
due to confluence. Initially cells needed a period to adapt to a new substrate,
from this derives a low viability during the first day of experiment. Similar
Figure 5.3.1: Fibroblasts viability seeded on cartilage scaﬀolds respect to control
cellular density at the third day was confirmed by DAPI staining (figure 5.3.2 on
the following page). There are not so diﬀerences between cells on scaﬀolds and
control cells.
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Figure 5.3.2: Dapi staining for (a) fibroblasts on cartilage scaﬀolds and (b) on
gelatin/collagen coating (control) at third day.
5.3.2 SEM micrographies
On 22.5% w/v HA scaﬀolds, cells had a good spreading degree even if it seemed
to be not homogeneous (figure. 5.3.3 on the next page). A good proliferation
degree and an uniform cell distribution over the entire biomaterial surface were
evident on 47.5% HA scaﬀolds. Furthermore there were a good cell interaction
and a good material adhesion (figure 5.3.4 on the facing page). 60% HA scaﬀolds
presented an inhomogeneous surface that led to a reduced interaction with cells
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accordingly with a poor cell spreading (figure 5.3.5 on the next page). Increasing
HA concentration to 70%, surface showed many hollows. Cells were few and with
an elongated form (figure 5.3.6 on the following page). Onto 80% HA scaﬀolds
there was a poor cell-substrate interaction with consequently few cells (figure 5.3.7
on the next page). Cells on 90% HA scaﬀolds, were not only elongated but they
presented some degenerative protrusions (figure 5.3.8 on page 85).
Figure 5.3.3: SEM of 22.5% HA samples at 500X and 1000X magnification.
Figure 5.3.4: SEM of 47.5% HA samples at 500X and 2000X magnification.
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Figure 5.3.5: SEM of 60% HA samples at 500X and 2000X magnification.
Figure 5.3.6: SEM of 70% HA samples at 250X and 1000X magnification.
Figure 5.3.7: SEM of 80% HA samples at 500X and 1000X magnification.
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Figure 5.3.8: SEM of 90% HA samples at 1000X magnification.
5.3.3 SEM-EDX micrographies
SEM-EDX microanalysis tecnique revealed a diﬀerent Ca and P distribution in
analyzed samples. 60% HA sample had Ca (red in figure) 66% wt, and P (green
in figure) 34% wt while 70% HA sample had on surface Ca 71% wt and P 29%
wt as showed in figure 5.3.9. Protrusions observed in cells onto 90% HA scaﬀolds
were inclusion of HA confirmed by microanalysis, Ca 69% wt and P 31% wt
(figure 5.3.10 on the following page).
Figure 5.3.9: SEM-EDX of (a) 60% HA and (b) 70% HA samples showing Ca
(red) and P (green) distribution.
85
5.4. Conclusions Chapter 5. In vitro tests
Figure 5.3.10: SEM-EDX of 90% HA sample showing Ca (red) and P (green)
inclusions and distribution.
5.4 Conclusions
Cartilage biomaterials showed a good biocompatibility, even if cells required a
period to adapt to the new substrate. As far as bone subsitute there was a
threshold HA concentration, above which the surface roughness becomes unsuited
to cells and HA passes from to be bioactive to be toxic. In fact cells had a
good spreading and adhesion till 47.5% HA sample, they become suﬀering from
60% HA samples to degenerate till including HA at 90%. So even if scaﬀolds
containing much than 60% HA, showed a suited Young’s modulus to be used as
bone substitute, they resulted unfit for cell growth.
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In vivo tests
Abstract
This chapter will be present in vivo tests of bone and cartilage polymeric systems
carried out on Wistar rats. Cartilage damage was performed on cartilage knee
while bone defect on femur at diaphysis level. Bone and cartilage regeneration
were assessed after 45 days from implantation with in vivo micro-CT and after 3
months with in vivo and ex vivo micro-CT and histology.
6.1 Introduction
In this chapter besides biocompatibility of biomaterials, injectability was tested
in animal model. Only some HA concentrations of bone biomaterials were tested
in vivo and they were chosen on the basis of the most promising Young’s mod-
ulus. Injectable materials do not require invasive surgery, so they reduce most
of the complications normally present in routine surgery. Injectable alginate
scaﬀolds cross-linked with calcium and incorporating chondrocytes, have been
studied. These systems induce cartilage repair, but they are unstable and un-
able to reproduce a functional tissue repair [69]. This response perhaps is due
to immunogenic eﬀect of alginate that induces the increase of lymphocytes and
anti-alginate antibodies. Synthetic injectable polymers have also been tested as
matrixes for chondrocyte grafts, such as polyethylenoxide (PEO) and copoly-
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mers with propylene PEO-co-PO (propylene oxide), that have shown a more
physiological cartilage regeneration respect to PGA or alginate scaﬀolds [70]. A
novel biocompatible and biodegradable hydrogel comprised of poly(ethylene gly-
col), gelatin, and genipin, was tested as an injectable biomaterial in combination
with a cyanoacrylate-based surgical sealant for cartilage repair[71]. The results
demonstrated that the hydrogel is biocompatible and biodegradable, and that the
cyanoacrylate-based surgical sealant is a relatively safe option for maintaining the
hydrogel in the defect.
6.2 Experimental section
6.2.1 Implantation procedure
Guidelines laid by the “Istituto Superiore di Sanità” for animal testing were fol-
lowed performed with the approval of the Local Ethical Committee and in accor-
dance with the European Communities Council Directive of 24 November 1986
(86/609/EEC). Surgery was carried out on Wistar rats under deep anesthesia.
The patella of left leg was dislocated medially and an osteochondral knee defect
was created on femoral ephysis using the tip of tweezers. Cartilage substitute
was prepared in sterile condition following the protocol described in chapter 3
and it was injected when the solution became blue (figure 6.2.1). Bone damage of
Figure 6.2.1: Cartilage biomaterial injenction in rat knee.
about 5 mm of diameter was produced onto right and left femur (diaphysis) us-
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ing a drill, in Wistar anaesthetized rats, involving cortical and spongy bone. The
right femur was used as control the other one was treated with bone biomaterial
with 70%, 80% and 90% HA (fig. 6.2.2).
Figure 6.2.2: Bone biomaterials implantation in left rat femur.
6.2.2 Micro CT analysis
In vivo micro-CT was performed on anesthetized rats after 45 days and 3 months
from implants using The Xalt scanner (X-ray AnimaL Tomograph), a dedicated
in vivo cone beam mCT for small animals, designed to provide flexible geome-
try setup and scanning modality. It was built in the framework of a collabora-
tion between the Institute of Clinical Physiology (IFC-CNR) and the Functional
Imaging and Instrumentation Group (FIIG) of the University of Pisa. After in
vivo µCT at third month, rats were deeply re-anesthetized and euthanized and a
high-resolution µCT was performed on explanted femurs.
6.2.3 Histology
Femurs were fixed in phosphate-buﬀered 4% formaldehyde solution for more than
24h. After fixations, samples were decalcified in 10 ml of electrolytic decalcify-
ing solution (Bio-Optica, Milan, Italy) containing hydrochloric acid and formic
acid, for two days. Once that diaphysis lesion was identified it was sampled by
performing three cuts perpendicular to the major axis of the bone. Two cuts
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were slightly distant from lesion and the other was in the middle of it, in order
to obtain two bone cylinders, each containing half lesion. Then cylinders were
embedded in paraﬃn, and a serial of coronal sections thickness of 5 µm were
performed. Some sections were stained with eosin and hematoxylin. The same
protocol was followed for epiphysis femoral lesion (cartilage damage) with the
exception that bone was sectioned orthogonally respect to its major axis and
longitudinally through the center of the trochlea to obtain half lesion for each
sample.
6.3 Results
6.3.1 In vivo µCT
A quantitative analysis was conducted for diaphysis lesions where bone biomate-
rials were applied. In vivo µCT images were elaborated using ImageJ software,
and bone volume was considered as bone regeneration parameter at 45 days and
100 days. There was no improvement in bone repair in the left leg (treated)
respect to the right leg (control) after 45 days and also after 100 days for all HA
concentrations tested as data show in figure 6.3.1. Unfortunaltely there were no
data for 90% HA after 45 days, because rats died after first µCT session. While
Figure 6.3.1: Bone volume of left and right legs after 45 days and 100 days.
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physiologic bone regeneration between 45 days and 100 days was evident more in
70% HA rats for both legs than 80% HA. The same analysis was impossible to
repeat with cartilage substitutes, because we wanted to see if biomaterial helped
cartilage repair (normally cartilage doesn’t repair itself) so at the end of experi-
ment we looked at eventually new cartilage in injury site. And even if we wanted
to compare cartilage repair between the two temporal spaces, the low resolution
of images made the damage diﬃcult to identify. Only after high resolution ex
vivo µCT was possible to see the damage.
6.3.2 Ex vivo µCT
High resolution of images allowed to calculate also bone surface that includes
lacunae surface so making the ratio bone volume/bone surface, we had a more
reliable data for bone regeneration. In the following table 6.1 we compare this
ratio between right leg (control) and left leg (treated).
%HA Femur bone volume (BV)/bone surface (BS)
70 Right 0.318
Left 0.331
80 Right 0.325
Left 0.317
90* Right 0.335
Left 0.326
Table 6.1: Bone volume, bone surface ratio as parameter for bone regeneration
for all HA tested;*reﬀered to a period inferior to 100 days.
All values, for both right and left legs were inferior to one and similar among
them, which meant that there was no improvement after biomaterial application
and that surface of considered bone section was bigger than volume (fig. 6.3.2 on
the following page and 6.3.3 on page 93). Ex vivo images, showed clearly the
epiphysis femoral lesion also after 100 days after cartilage sustitute application
(fig. 6.3.4 on the following page).
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Figure 6.3.2: Axial plane of (a) right and (b) left femur of rats with 80% HA
biomaterial.
Figure 6.3.4: Ex vivo high resolution image of cartilage damage after 100 days
from biomaterial implant.
6.3.3 Histology
With regards to macroscopic aspect at diaphysis level it appeared as an area of
depression of the bone profile in all femurs (treated and control) figure 6.3.5.
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Figure 6.3.3: Sagittal plane of (a) right and (b) left femur of rats with 80% HA
biomaterial.
Figure 6.3.5: Macroscopic identification of diaphysis lesion.
At microscopic level were visible endosteal and periosteal irregularities of rea-
sonable extent. Cortical bone thickness was reduced uniformly (fig. 6.3.8 on
the next page) in all samples and were visible medullary spaces, numerous new
osteocytes, blood vessels and cement at reversal lines signs of starting bone re-
generation (fig. 6.3.6 on the following page). There was no osteoclasts and no
inflammation but were visible some Howship lacunae (fig. 6.3.7 on the next page).
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Figure 6.3.6: Microscopic images: (a) medullary spaces and (b) blood vessels and
new osteocytes in cortical bone.
Figure 6.3.7: (a) Periosteal (left femur) and (b) endosteal (right femur) Howship
lacunae.
Figure 6.3.8: (a) Reduced cortical thickness, medullary spaces; (b) irregular en-
dosteal profile.
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Epiphysis femoral lesion at a macroscopic level was evident in the center of
the trochlea (fig. 6.3.9). At a microscopic level, cartilage had a damage, with a
triangular form involving also cancellous bone. Bone damage was totally filled
with fibrous tissue and there were few osteoclasts at this level (fig. 6.3.10). With
histology techniques used was impossible to identify remaining biomaterials.
Figure 6.3.9: Macroscopic identification of epiphysis femoral lesion.
Figure 6.3.10: Cartilage damage, and cancellous bone replaced with fibrous tissue.
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6.4 Conclusions
Both micro-CT and histology confirmed that bone and cartilage damage after
100 days from implantation of biomaterials were still present. There were no
diﬀerences between right (control) and left (treated with biomaterial) femurs for
all HA concentrations injected. A reason could be that bone biomaterial was
ineﬀective, also considering in vitro data, or simply it didn’t remain in contact
with lesion enought time to be colonized by cells. Important was the absence of
imflammation state. The same consideration can be applied to cartilage. Further,
because of the non invasive surgery technique to create a cartilage lesion used in
these experiments, was impossible to assess the inital damage and to follow the
progress of regeneration. From histology performed at 100 days, we knew that
the damage involved also bone and that the physiologic cartilage repair started,
that is replacement of tissue with fibrous one, and so that there was no new
cartilage tissue.
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Conclusions
The aim of this research was to test some biomaterials as bone and cartilage
sustitutes. Biomaterials studied were a polymeric mixture of hydrogel, gelatin
and collagen type I, that as natural substances are biocompatible, biodegradable
and chemo-attractor. The main problem with the use of hydrogel is their rapid
dissolution in an aqueous environment, so a crosslinking agent was necessary.
Genipin was chosen, because it is natural, it ensures an eﬃcient reaction and it
is much less toxic than the other crosslinkers commonly used. In literature, there
were many mechanical and chemical data, about gelatin and genipin scaﬀolds,
but nothing with the inclusion of collagen. So fundamental was the character-
ization of reaction (rate constant, diﬀusion coeﬃcient and crosslinking degree).
From data collected, with particular attention to GP toxicity, its best concen-
tration was decided for cartilage and bone scaﬀolds. Equally important were
mechanical tests performed on cartilage scaﬀolds at diﬀerent GP concentrations,
and on bone scaﬀolds at diﬀerent HA concentrations. Elastic modulus of carti-
lage scaﬀolds calculated did not mimic that of native tissue but the presence of
chemo-attractors (collagen) within them should help to produce fast cell coloniza-
tion. Mechanical test results helped the choice of the best preparation protocol
for bone scaﬀolds. Their Young’s modulus could be adjust changing HA con-
centration till reaching the cancellous bone modulus after scaﬀolds dehydration.
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The same scaﬀolds were used to realise discrete gradient samples, simply stacking
two or more homogeneous HA scaﬀolds, to reflect more accurately phisilogycal
bone structure. Anisotropy, one mechanical bone feature, was verified particular
for multilayered scaﬀolds. Considering that those biomaterials should be used
after a trauma, and that it involves a pH variation, possible elastic modulus
changes at pH 5, 6, 7, 8 were investigated only for homogeneous scaﬀolds. In fact
modulus respect to physiologic pH, decreased in acid condition (pH 5), while it
increase at slightly basic pH. After mechanical studies, preliminary in vitro tests
were performed to assess biocompatibility of polymeric systems. Primary fibrob-
lasts seeded onto cartilage scaﬀolds showed an increasing viability across 3 days,
till reaching control value at the end of experiment. Bone scaﬀolds were seeded
with MG-63 human osteoblast-like cells, and they were analysed with SEM and
SEM-EDX. A good cells spreading and adhesion was verified only for low HA
concentration, starting from 60% HA cells became suﬀering to degenerate till in-
cluding HA at 90%. In spite of these results, high concentration HA biomaterials,
togheter with cartilage one, were tested in vivo as injectable. Lesions were made
on femur rats, where biomaterials were applied. Bone and cartilage regeneration
was verified after 45 days and after 100 days with in vivo micro CT analysis.
Animals were sacrified at the end of experiment (100 days) and ex vivo micro CT
(high resolution micro CT) and histology were performed. Both analyses con-
firmed that there was no improvement in bone regenaration in the treated femur
respect to the physiologic bone repair. The osteochondral lesion was partially
repaired with fibrous tissue and not with new cartilage. Biomaterials can’t be
label as ineﬀective with absolute certainty, because it was impossible to detect
them at 45 days with ￿CT and also at 100 days with histology. Since HA usu-
ally needs many years to be degradeted, probably biomaterial didn’t remain onto
lesion enough time to be colonized by cells so it should be injected when it will
assume a higher viscosity, typical of an advanced stage of crosslinking reaction.
Biomaterials formulated and tested in this research, show promising mechanical
properties but they need more in vivo investigations, particular for bone scaﬀolds
at low HA concentrations.
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